Abstract
Intervertebral disc (IVD) degeneration (IDD) is the main contributor to chronic low back pain. To date, the present therapies mainly focus on treating the symptoms caused by IDD rather than addressing the problem itself. For this reason, researchers have searched for a suitable biomaterial to repair and/or regenerate the IVD. A promising candidate to fill this gap is silk, which has already been used as a biomaterial for many years. Therefore, this review aims first to elaborate on the different origins from which silk is harvested, the individual composition, and the characteristics of each silk type. Another goal is to enlighten why silk is so suitable as a biomaterial, discuss its functionalization, and how it could be used for tissue engineering purposes. The second part of this review aims to provide an overview of preclinical studies using silk‐based biomaterials to repair the inner region of the IVD, the nucleus pulposus (NP), and the IVD's outer area, the annulus fibrosus (AF). Since the NP and the AF differ fundamentally in their structure, different therapeutic approaches are required. Consequently, silk‐containing hydrogels have been used mainly to repair the NP, and silk‐based scaffolds have been used for the AF. Although most preclinical studies have shown promising results in IVD‐related repair and regeneration, their clinical transition is yet to come.
Keywords: Bombyx mori, degeneration, functionalization, intervertebral disc, low back pain, regeneration, repair, silk, stem cells
For years, researchers have been seeking a suitable biomaterial to repair and/or regenerate the intervertebral disc (IVD) and a promising candidate to fill this gap could be the application of silk. Therefore, this review aims to elaborate on the different origins from which silk is harvested, the characteristics of each silk type and how it can be used for tissue engineering purposes. Moreover, the review provides an overview of preclinical studies that have used silk‐based biomaterials to repair the inner region of the IVD, the nucleus pulposus, as well as the IVD's outer region, the annulus fibrosus.

Abbreviations
- ACAN
aggrecan
- AF
annulus fibrosus
- ASmiR‐214
anti‐sense miR‐214
- BMP
bone morphogenetic protein
- Bombyx mori
B. mori
- CAD
computer‐aided design
- COL1
collagen type I
- COL2
collagen type II
- CS
chondroitin sulfate
- ECM
extracellular matrix
- GAG
glycosaminoglycan
- GDF‐6
growth and differentiation factor 6
- GF
growth factor
- GlcNAc
N‐acetyl‐glucosamine
- GMO
genetically modified organism
- HA
hyaluronic acid
- IDD
intervertebral disc degeneration
- IVD
intervertebral disc
- LBP
low back pain
- MaSp
major ampullate spidroin
- miRNA
microRNA
- MSC
mesenchymal stromal cell
- NP
nucleus pulposus
- PLGA
poly(lactic acid‐co‐glycolic acid)
- PTH
parathyroid hormone
- RGD
arginine‐glycine‐aspartic acid
- SELP
silk‐elastin‐like protein
- SF
silk fibroin
- SOX9
SRY‐box transcription factor 9
- SS
silk sericin
- TGF‐β
transforming growth factor β
- VEGF
vascular endothelial growth factor
1. INTRODUCTION
1.1. The burden of low back pain and intervertebral disc degeneration
Every year, 266 million people worldwide report suffering from low back pain (LBP), with the highest incidence in Europe (5.7%). 1 The reasons for LBP are versatile. However, the main contributor to chronic LBP is intervertebral disc (IVD) degeneration (IDD). 2 Compared to other organs of the musculoskeletal apparatus, the onset of IDD often starts in early adolescence and then progressively aggravates with age. 3 , 4 , 5 The beginning of IDD is thought to be multifactorial, and many risk factors such as excessive mechanical stress, 6 genetics, 7 trauma, 8 and nutritional disorders within the IVD 9 can set the ball rolling responsible for the progression of IDD. And once the vicious circle of IDD is entered, it is of great challenge to escape it and reverse the process. 10 IDD usually starts in the IVD's inner region, known as the nucleus pulposus (NP). 11 The NP acts as the IVD's central pressure and weight absorber, which it is capable of due to its highly hydrated nature and abundance of collagen type II (COL2), elastin fibers and proteoglycans like aggrecan (ACAN). 12 , 13 During IDD, biochemical and cellular changes occur that promote catabolic turnover. 14 Hence, the NP's osmotic balance gets disturbed and consequently dehydrates. 11 Decreased hydration of the NP causes a shift of the compressive load from the NP to its surrounding tissue, the annulus fibrosus (AF), which is comprised of multiple concentric ring‐like layers (lamellae) that are rich in collagen type I (COL1). 15 , 16 However, as the structure of the AF is preferentially made to resist tensile forces and less compressional forces, it becomes stiffer and weaker and aggravates the IVD's degeneration process overall. 15 As a result, the IVD can bulge and cause disc herniation with associated discogenic pain. 17
To date, the clinical management of IDD has proven to be suboptimal in many cases since the current therapy methods primarily target the symptoms of IDD, mainly pain, and not the pathophysiology itself. 18 This issue can be largely traced back to a lack of available treatment options that would encourage the repair or regeneration of the IVD. 19 However, as an IVD is characterized by a low cell density, low turnover, avascularity, and poor nutritional supply, it poses a considerable challenge to researchers attempting to repair it. 20 Nevertheless, novel biomaterial‐based therapies for the treatment of IDD have attracted considerable attention in recent years. 21 Biomaterial‐based therapies have the great advantage of preserving the IVD's structure while either already containing cells that drive the regeneration and repair or stimulating the regenerative potential of the remaining cells in the tissue. 21
One biomaterial that has historically been used time and time again for biomedical applications is silk. 22 Moreover, in orthopedics and especially in IVD‐related research, silk was often used to support the IVD's repair or regeneration. 23 Therefore, this review aims to elaborate on the sources, types and properties of silk, how it has been used as a biomaterial and mainly, how the introduction of silk into IVD‐related research has been implemented to repair the damage caused by IDD and to counteract further degeneration of the IVD.
1.2. Silk—properties and the various species from which it can be harvested
Many insects and arachnids produce silk biopolymers as a protective shield during their life, such as the silkworms (Insecta: Lepidoptera: Bombycidae), 24 spiders (Chelicerata: Arachnida), 25 mites (Chelicerata: Arachnida: Acari: Tetranychidae), 26 and wasps (Insecta: Hymenoptera). 27 The most popular type of silk, mulberry silk, accounts for most silks produced globally (about 95%) (Figure 1). 28 Other commercially essential types of silk are classified as non‐mulberry silk since they do not feed on mulberry plant leaves. The prominent representatives of this group are Eri silk, Tasar (Tussar) silk and Muga silk (all Insecta: Lepidoptera: Saturniidae) (Figure 1). 29 On the other hand, there is spider silk with its outstanding mechanical properties 30 ; however, its commercialization is limited by the high‐cost production and the difficulty in obtaining more significant amounts with the exception of some novel gene technology approaches. 22 , 31 Silks from silkworms and spiders have been widely studied for their use in tissue engineering and regenerative medicine. 32 , 33 , 34 Depending on the source, the biological and physicochemical properties change due to the different structural compositions. 35 , 36 , 37
FIGURE 1.

A schematic of silk origins and how it is applied for biomedical applications. (A) Sources of arthropod‐derived silk. (B) Various forms of silk scaffolds for various biomedical applications: silk foams (redrawn, based on Hardy et al. 135 ), silk hydrogels (redrawn, based on Singh et al. 131 ), sponge‐like silk (redrawn, based on Yu et al. 132 ) and woven silk (redrawn, based on Hofmann et al. 250 )
1.2.1. Mulberry silk
Commercially available mulberry silk is produced from a single species, i.e., Bombyx mori Linnaeus, 1758 (Figure 1). Mulberry silkworms are entirely domesticated, and they do not occur naturally. 38 The silk protein is secreted from the silk glands of the mature fifth instar larva. 39 Their cocoon is formed by a structural protein core, that is, silk fibroin (SF), surrounded by a water‐soluble coating named silk sericin (SS). 40 SF constitutes the significant portion of the cocoon and is the core silk protein. It is the same protein reeled from the cocoons into threads to be woven into cloth that forms a significant source of income for the sericulture industry. 41
SF from B. mori is composed of a heavy chain (H‐chain, 360–390 kDa) and a light chain (L‐chain, 27 kDa), which are held together by a disulfide bond and a glycoprotein called P25, which is linked to both chains by noncovalent interactions in the molar ratio of 6:6:1, respectively (Figure 2). 42 , 43 , 44 The primary structure of the H‐chain is a polypeptide that is mainly composed of glycine (43%–46%, G), alanine (30%, A), serine (12%, S), tyrosine (5.3%, Y) and other amino acids. 45 , 46 , 47 A SF H‐chain is designed as a natural block‐copolymer with a repetitive core formed by 12 domains forming the crystalline region of SF interspersed with 11 less organized domains composed of a nonrepetitive primary sequence. 35 , 43 This block‐copolymer arrangement of the H‐chain guarantees the characteristic mechanical properties of SF. 48
FIGURE 2.

Chain configuration of silk fibroin: (A) Schematic representation of the primary structure of the silk fibroin heavy chain. Each of the 12 crystalline domains varies slightly in length and sequence, while the 11 amorphous domains are nearly identical. The amino acid sequence for one of the crystalline domains is given to highlight the repetitive nature of the protein. (B) Hierarchical structural organization in Bombyx mori silk fibroin. (i) Orientation of aligned beta‐sheet crystallites and amorphous regions within a native fiber. (ii) Inter‐sheet stacking within a beta crystallite, held together by van der Waals interactions between the glycine or alanine populated faces. (iii) Hydrogen bonding in the peptide chain organizes the crystalline blocks of the protein into anti‐parallel beta‐sheets
The other protein constituting the silk cocoon is SS, a globular protein. It is an amorphous glycoprotein that acts as a cement to keep the SF filaments together during the spinning process and comprises about 20%–30% of the cocoon's mass. Its primary structure is mainly composed of serine (28%–34%), glycine (10%–19%), aspartic acid (14%–19%), and in minor parts, other amino acids such as histidine, tyrosine, glutamic acid, threonine, and others. 49 , 50 The high serine content and the polar side domains of other amino acids (hydroxyl, carboxyl, or amino groups) make it highly water‐soluble. Moreover, they enable crosslinking, copolymerization, and blending.
SS obtained from B. mori exists mainly as random coil conformation with a molecular weight ranging between 20 and 400 kDa. 49 A small percentage of beta‐sheets, along with beta‐turns, contributes to small crystalline domains. 51 However, due to the principal presence of random coils, it behaves like an amorphous material, brittle in the dry state. Its properties can be improved by triggering beta‐sheet formation upon drying, mechanical stretching, moisture absorption, or chemical modifications.
The process of removing sericin from the silk fiber is named degumming. To extract and use sericin from the cocoon, different methods can be chosen: high temperature (with or without high pressure) by autoclaving, acidic solution (citric, tartaric, succinic acid), soap, and alkali solutions (sodium carbonate), highly concentrated urea or by enzymatic processes. 52 , 53 , 54 With different extraction protocols, the chemical structure of sericin and its amino acid composition changes, which could impact the potential biomedical application. 54 , 55 , 56 The degumming process is also fundamental for the extraction and regeneration of silk fibroin into an aqueous solution and for the structural integrity of the three subunits of the silk fibroin protein complex. 57 Thus, it is often a crucial first step for developing silk‐based biomaterials.
In addition to SF and SS, the major silk proteins, several components of low molecular weight peptides have been identified. These silk protein components are called seroin. 58 Seroin is distinguished from other silk proteins by high proline content, lack of cysteines, and the presence of two kinds of short amino acid repeats. 58 It is assumed that seroin is involved in cocoon protection against predators and microbes. 59
1.2.2. Non‐mulberry silk
Representatives of non‐mulberry or “wild” silks are called tasar, eri, muga, fragaria, cricula (collectively called “Vanya silks,” coming from Sanskrit language and standing for untamed, wild, or forest‐based, Lepidoptera: Saturniidae), and shashe (Lepidoptera: Lasiocamidae) (Figure 1). 60 The process of non‐mulberry silk production in the silkworm gland is the same as the mulberry silk. However, the spun silk displays significant characteristic differences. 61 A prominent feature is that non‐mulberry silk has a higher cross‐section since it has reduced packing capacity due to the higher content of bulky side‐groups in the H‐chain (dibasic acids and arginine). Its stability results from higher H‐bonds in the H‐chain, which limits the dissolution. Moreover, non‐mulberry silks are more stable at high temperatures than mulberry silks and present attractive compressive strength, toughness, and elasticity. 29 , 62 , 63 The amorphous domains are formed by bulky and polar side chains, responsible for maintaining the silk properties under different external treatments. Finally, non‐mulberry silk does not possess an L‐chain and the P25 glycoprotein. 64 , 65 The big challenge with non‐mulberry silk is the isolation and purification of SF from the cocoon. This difficulty arises from the high hydrophobic structural stability of non‐mulberry cocoons and the high amount of H‐bonds. They cannot be dissolved in lithium bromide and the other solutions used for mulberry silks. Therefore, other ionic liquids such as calcium nitrate, sodium thiocyanate, lithium thiocyanate and harsh organic solvents, such as trifluoroacetic acid, have been considered. 66 , 67 Due to this issue, non‐mulberry SF is generally isolated from the silk gland of the fifth instar larvae by squeezing it in a distilled water solution with anionic surfactants. 68
A selection of non‐mulberry silks and their properties is presented in Table 1.
TABLE 1.
Properties of various non‐mulberry fibroin and sericin
| Silk type | Silkworm species | Background | Silk proteins | Molecular weight (kDa) | Breaking strain (%) | Reference |
|---|---|---|---|---|---|---|
| Tasar silk |
Antheraea mylitta Antheraea perny Antheraea yamamai Antheraea roylei |
Can be divided into two types: tropical tasar and temperate tasar. These silkworms can be bivoltine or trivoltine depending upon variety and habitat. Among non‐mulberry silkworms, A. mylitta has the highest silk production capacity and its cocoon is the largest. | Fibroin | Two fractions of 395 and 197 | 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 | 68, 223, 224 |
| Sericin | Five fractions ranging from 30 to more than 200 | |||||
| Muga silk | Antheraea assama | Muga is golden yellow colored silk and is mostly distributed in the north‐eastern region of India. The silkworms are semi‐domesticated and multivoltine. | Fibroin | Two fractions of 20 and 220 | 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 | 223, 225, 226 |
| Sericin | Single fraction of 66 | |||||
| Eri silk | Philosamia ricini (Samia ricini/Cynthia ricini) | Eri silk can regain greater amounts of moisture than mulberry silk. Its fibroin contains a many hydrophilic and positively charges amino acids. The silkworms can be domesticated, and they eat the leaves of several trees, not just mulberry leaves. | Fibroin | Two fractions of 45 and 97 | 24, 25, 26, 27 | 223, 225, 227, 228 |
| Sericin | Single fraction of 66 | |||||
| Fagaria silk | Attacus atlas | Attacus atlas can be found in southeast Asia. Its silk has a bivoltine nature and the tensile strength of the silk yarn is greater than that of tasar and muga. | Fibroin | N/A | N/A | 60, 229, 230 |
| Sericin | N/A | |||||
| Shashe silk | Gonometa postica | Gonometa postica is a polyphagous African insect. Its high‐quality silk has mainly been used for textiles and has only recently been implemented as a biomaterial. | Fibroin | N/A | 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 | 231, 232, 233 |
| Sericin | N/A | |||||
| Cricula silk | Cricula trifenestrata | Cricula trifenestrata is a silkworm from South Asian countries. The cocoons of this species are small and perforated. The silk has good biocompatible properties. | Fibroin | Single fraction of 400 | 12 | 60, 234, 235, 236 |
| Sericin | Single fraction of 350 |
Source: Modified from Kundu et al. 60
1.2.3. Spider silk
Spiders produce spin silks to perform many functions, such as mating, 69 flying, 70 and building their webs for hunting (Figure 1). 71 Among these, spider cobwebs are the most well‐known ones. They are composed of at least five types of silk (i.e., minor and major ampullate silks, piriform silk, flagelliform silk and aggregate silk), produced by different glands with various functional properties. 72 , 73 , 74 , 75 The most extensively characterized spider silks are from Nephila clavipes and Araneus diadematus. 22
Spider silk provides a greater diversity of physical and mechanical properties than silkworm‐derived fibers due to multiple complex silk glands. 72 Silk derived from the spiders' major ampullate glands is a natural hierarchically ordered material that displays a unique combination of the tensile strength (1.3 GPa), extensibility (30% elongation to fracture) and toughness (158–180 J/cm3). In contrast to B. mori silk, spider silk does not comprise any sericin. 76 , 77 , 78 , 79 , 80 Moreover, it is biocompatible and has a very high strength‐to‐density ratio, exceeding the one of high‐performance steels and many commercial fibers. 81 For these reasons spider major ampullate silk has always inspired researchers in the design of biomedical devices and tools with outstanding mechanical and biological properties. 32 , 82 , 83
Unlike silkworms, which rely on two essential proteins—sericin and fibroin—spiders manufacture proteins (spidroins) whose composition and properties vary significantly between species. 84 However, they consist of two nonrepetitive hydrophilic terminal domains (amino‐ and carboxy‐terminal) with a large internal repetitive hydrophobic region. 85 Major ampullate silk is mainly composed of major ampullate spidroin (MaSp) 1 and 2 that comprise poly‐alanine and poly‐glycine‐rich domains in the repetitive region. 86 It contains crystalline beta‐sheets formed by poly‐alanine interconnected in an amorphous matrix composed of glycine. 87
Despite the remarkable properties, native spider silk has limited uses as it is very challenging to achieve more extensive mass production. One reason for these limitations might be the cannibalistic nature of spiders, which makes it hard to harvest silk on a large scale. 88 A possible solution to overcome this hurdle is the production of artificial spider silk through their expression in heterologous hosts, such as bacteria. 89 Recently, it has been proposed to use plants such as potatoes and tobacco to amplify spider silk proteins for the industry. 31 Aside from increased scalability, protein engineering techniques allow scientists to design artificial silks with specific features that could outperform native spider silk for their use in the biomedical field, in textiles and others. 90
2. SILK AS A BIOMATERIAL
Biomaterial design is a fundamental ingredient of tissue engineering. An ideal biomaterial should: (i) be biocompatible and elicit little to no host immune response, (ii) integrate physical, chemical, and biological cues to guide cells into functional tissues via cell attachment, migration, proper cell–cell interactions, cell proliferation, and differentiation, (iii) degrade at a rate favorable with new tissue formation, (iv) offer mechanical support appropriate to the level of functional tissue development, and (v) possess versatile processing options and should be easily chemically modified to suit a wide range of targeted biomedical applications. 91
Silks represent a unique family of proteins that fulfill all these criteria of a functional biomaterial. 80 The most studied silk type for biomaterial design is mulberry (B. mori) silk because it can be domesticated and regenerated in an aqueous solution. Non‐mulberry silk is not widely used in the field of biomaterials, despite the presence of the tripeptide sequence arginine‐glycine‐aspartic acid (RGD) in the primary structure, which would enhance the interaction of integrin present on the cells' surface, giving non‐mulberry silk an advantage over mulberry silk to enhanced cell adhesion and proliferation. 92 , 93 , 94 As previously mentioned, the use of non‐mulberry silk, is hindered by cocoon dissolution issues, so harvesting is almost limited to direct extraction from the silk glands. Nevertheless, there are studies for its use as a potential biomaterial for different target tissues (bone, 95 cartilage, 96 skin, 97 tendon, 98 cornea 99 ), for drug delivery 100 and as tissue models. 101 , 102 Finally, since the spread of spider silk as a biomaterial is limited because of the difficulties in obtaining large quantities of material, there is considerable interest in the production of recombinant spider silk proteins using heterologous hosts. 88 , 103 To date, silk has been processed in the form of fibers, 104 non‐woven meshes, 105 films and coatings, 106 porous forms, 107 hydrogels, 108 and bioinks 109 , 110 for tissue engineering purposes (Figure 1B).
2.1. Silk fibroin
SF from B. mori is an attractive biomaterial that has been used as suture material since ancient times. Meanwhile, some SF‐based products have been approved by the FDA for their use in clinics. Degummed SF yarns are used for surgical sutures and for manufacturing the knitted surgical mesh (SERI surgical scaffold™). 32 Furthermore, a powder from freeze‐dried regenerated silk fibroin solution is used as an injectable filler (Silk Voice™) for vocal fold medialization and vocal fold insufficiency. 37 , 111 One reason for the excellent biocompatibility of SF may depend on the crystallinity content and the method of material processing. 112 As an example, the thrombogenic response of regenerated SF films can be tuned by varying their beta‐sheet content and decreasing their hydrophobicity so that they adsorb more serum proteins compared to the native fibers. 113
The regeneration of SF is fundamental for obtaining an aqueous solution that can be processed in diverse ways by controlling and triggering the self‐assembly of beta‐sheets “on‐demand” for the crystallization structure. The key features that make SF an exciting choice for tissue engineering applications are its tuneable biocompatibility, 114 low immunogenicity, 115 tuneable biodegradation, 116 versatile processability, 117 controllable and tailorable mechanical properties, 118 and its sustainability (easy accessibility, cost‐effective and green processing). 119
A soluble helical structure dominates the regenerated aqueous solution (Silk I‐like). 45 When this structure is exposed to mechanical/physical and chemical treatments, the transition to Silk II occurs. 120 Silk II is a beta‐sheet crystal‐dominated structure and is the main contributor to the SF's strength, biodegradation kinetics, biological response and insolubility in water and other solvents, such as mild acids and alkaline environments. Depending on the beta‐sheet content and the self‐assembling method, the physicochemical and biological properties of the scaffold vary. 121
When dealing with scaffolds, it is essential that their degradation kinetics are consistent with the rate of novel tissue formation. The relevant advantage of SF is that its degradation can be controlled by tuning the crystallinity, concentration, molecular weight, the scaffold morphology, such as scaffold pore size, porosity and processing technique. 122 , 123 , 124 Being a protein, SF is subjected to proteolytic digestion in vitro and in vivo by chymotrypsin, proteases, collagenases and matrix metalloproteinases. 116 Each enzyme has a specific cleavage site, and protease XIV has been considered the most efficient for degrading silk in any material construct. 123 Due to their long‐term functional stability, porous silk scaffolds have been used in sustainable cultures for up to 6 months. 125
SF‐based scaffolds also display high thermal stability, depending mainly on the primary and secondary structure. 35 Silk I and Silk II crystals melt at different temperatures, that is, 260–292°C and 286–350°C as a mean value, respectively. 126 , 127 Also, the processing technique and post‐treatments influence the thermal stability of SF scaffolds. 128 Due to their thermal strength, SF‐based scaffolds can withstand different sterilization techniques, such as autoclaving, ethylene oxide, ethanol, and UV‐ and gamma irradiation, without damaging the structure. 129 This feature is a crucial difference from many other natural polymers.
The regenerated SF solution can be processed differently to produce different scaffold morphologies such as hydrogels, 130 , 131 , 132 foams 133 and sponges, 134 , 135 3D printed constructs, 136 micro‐ and nano‐particles, 137 electrospun membranes, 138 and 2D films (Figures 1B and 3). 139 This processing versatility allows it to adapt to the needs and requirements of different target tissues with diverse physicochemical and biological responses. 36 , 113 For example, hydrogels are highly hydrated polymer networks that can be crosslinked by other methods and permit cell seeding and encapsulation due to their capacity to retain large amounts of water. Hydrogels have been widely explored in tissue engineering because of their unique biocompatibility and biodegradability. 140 Usually, traditional SF‐hydrogels are based on physical and chemical crosslinking (summarized in Table 2). The properties of SF hydrogels depend on the number of beta‐sheets in the material. 141 Physical stabilization can then be achieved using shear stresses, 142 an electric field 143 and ultrasound 144 or varying the temperature 145 or pH 146 to allow the conformational change from Silk I to Silk II. Besides physical crosslinking, however, chemical crosslinking can also be involved to improve the stability and the mechanical properties thanks to the abundance of functional groups on SF chains (i.e., tyrosine, lysine). 130
FIGURE 3.

Illustration of recent advances of silk engineering for regeneration of spine applications. (A) Functionalization of silk, for example, with GMO modified Bombyx mori larvae overexpressing TGF‐β or GDF‐6 in silk glands based on ref or addition of RNA molecules such as miRNA, siRNA based on Frauchiger et al. 215 (B) Process of electrospinning of silk. (C) Microfluidics of B. mori/spider‐on‐chip strategies
TABLE 2.
Types of crosslinking used for silk fibroin hydrogels
| Crosslinking type | Methods | Main interactions |
|---|---|---|
| Physical crosslinking |
|
Noncovalent bonds (hydrogen bonding, hydrophobic interaction, electrostatic interaction, ionic interaction). 128 , 237 , 238 , 239 , 240 , 241 , 242 |
| ||
| Chemical crosslinking |
|
Formation of covalent bonds via enzymes, chemical agents or others. 150 , 152 , 243 , 244 , 245 , 246 , 247 |
| ||
Note: Sketches created in the Mind the Graph platform (www.mindthegraph.com).
Sponges and foams are interconnected porous structures whose properties can be controlled by the processing method. SF sponges can be produced by salt leaching, 147 freeze drying, 134 or gas foaming. 133 They have been widely used for orthopedic applications and soft tissue engineering due to their macroporous structure, which can be adjusted for tissue regeneration and vascularization. 148 Sponges and foams can also be used in combination with 3D printed synthetic polymer structures to promote the bioactivity of the construct. For example, in the past, SF was combined with a 3D printed polycaprolactone structure to fabricate an “entrapped in cage” scaffold for meniscus tissue engineering. 149 The presence of silk enhanced the mechanical properties in the wet state thanks to its swelling properties and favored cell adhesion, proliferation, and metabolic activity in vitro and neovascularization in vivo.
Due to its different chemical structure, the biocompatibility of SF can be enhanced by chemical modifications of the amino acid side chains to graft bioactive molecules (peptides, growth factors [GFs]). This process includes coupling reactions (i.e., carbodiimide chemistry, 150 , 151 diazonium coupling 152 or cyanuric chloride activated 153 ), which can facilitate the addition of another polymer chain, 154 oligosaccharides 155 or specific peptide chains. 156 A former study showed that biocompatibility was increased by the covalent addition of RGD and parathyroid hormone (PTH). 157 The scaffold biocompatibility can also be improved by blending SF with other materials, i.e. with calcium phosphates or specific inorganic components to enhance osteogenic properties. 158 Furthermore, silk fibroin scaffolds have also been shown to promote differentiation of mesenchymal stromal cells (MSC) with extracellular matrix (ECM) secretion and mineralization, making them an optimal candidate for orthopaedical tissue regeneration. 159 Moreover, the incorporation of specific GFs (i.e., bone morphogenetic protein 2 [BMP‐2], 160 BMP‐7, 161 vascular endothelial growth factor [VEGF]) 162 further increased the osteogenic and angiogenic potential of SF scaffolds.
2.2. Silk sericin
SS is a natural polymer protein material produced by the silkworm B. mori that covers and holds the silk fibroin filaments together. However, SS is usually considered a side‐product of the cocoon during the degumming process, becoming an unutilized waste product. Researchers started to extract it as biomaterial due to its natural origin, availability, and interesting biological properties. SS has been recognized as the immunogenic element of the silk filament for years, which has fuelled research into the purification of SF and its regeneration. However, researchers demonstrated that the immunogenicity of the silk fiber is mainly due to the combination of SS with SF, although the mechanism responsible for initiating the immune response is not yet fully understood. 163
SS has been used in cosmetics for years due to its properties such as antioxidant, 164 moisturizing, 165 UV‐protective potential, 166 and oxygen permeability. 167 For tissue engineering approaches, SS‐biomaterials have been synthesized in various forms, such as hydrogels, 168 sponges, 169 films, 170 and inks. 171 Furthermore, with the development of SS‐based 3D scaffolds and films, its biological effects could be investigated. SS showed an increase in the migration, proliferation and production of COL1 in skin cells. 172 Additionally, it favors the growth of keratinocytes and fibroblasts, which makes it a potential candidate for epithelial tissue repair and wound dressings. 173 Moreover, SS can favor the nucleation of bone‐like hydroxyapatite, raising interest in its use in bone tissue engineering and the coating of titanium surfaces. 174 , 175 Finally, due to its chemical reactivity, pH sensitivity and amphiphilic structure, SS has been employed for the design of drug delivery systems and for targeting purposes. 174
Despite the interesting biological properties, the widespread use of SS‐based scaffolding materials is limited because it is characterized by fast degradation rates and weak mechanical properties. However, thanks to the presence of hydroxyl, carboxyl and amino groups present in the polar side chains, it can be crosslinked, 176 co‐polymerized 177 and blended 178 with other polymers to improve biomechanical features or to conjugate bioactive molecules. For example, in a previous study, SS was combined with gelatin methacrylate, and it was then used as ink for 3D printing purposes favoring the proliferation and stratification of keratinocytes. 171
2.3. Functionalized silk
As mentioned above, silk as a biomaterial already has a lot of advantages in tissue engineering applications. However, when silk is fabricated into a scaffold with designed functions and in contact with the tissues, the microenvironment with which the scaffold is in contact is complicated, so the requirements of the material are more crucial. For this reason, the silk or silk‐based scaffold should be functionalized to have a controllable performance according to the final purpose. The general principle of functionalization is the use of physical or chemical methods to make silk as a delivery and sustainable controlled‐release system of some targeted molecules, in order to improve the tissue‐specific biological properties of the scaffold.
2.3.1. Growth factor and cytokine functionalization on silk
GFs and cytokines are two major biological signal molecules, which regulate cellular function, and have an essential contribution to ECM synthesis. 179 Since silk is a well‐studied material in this field, functionalized silk with GFs and cytokines has presented excellent performances in both delivering and releasing. In the past, the biological properties of the dual GFs BMP‐2 and transforming growth factor β1 (TGF‐β1) functionalized silk‐based (non‐mulberry silk fibroin, from Antheraea mylitta) scaffold have been studied for bone regeneration using different functional methods. Bhattacharjee et al. 180 loaded the two GFs using the carbodiimide‐coupling reaction, while Naskar et al. 181 loaded the same GFs by simple physical blending. Even though the architectures of these two studies were completely different, both results showed that the functionalized silk scaffolds had a sustained GF release profile, good cell adhesion, proliferation, and migration, as well as an earlier stage differentiation. In the study by Wang et al., osteochondral GFs were either encapsulated in poly(lactic acid‐co‐glycolic acid) (PLGA)‐based or mulberry SF‐based microspheres and then further incorporated in alginate or silk scaffolds to create concentration gradients. 182 The results showed that both microsphere types were able to form concentration gradients and induced human MSCs to differentiate along the concentration gradient into an osteochondral phenotype.
2.3.2. Functionalizing silk with miRNA
MicroRNAs (miRNAs) are short, noncoding RNA molecules that regulate gene expression. Importantly, due to the “small size” of these RNAs, the therapeutic miRNAs will not integrate into DNA, thus eliminating the scruples about genetic alterations (Figure 3A). 183 Although the regulation of miRNA on skeletal tissues is widely studied, the application of miRNA to functionalize silk or silk‐based scaffolds for tissue engineering is still an emerging field. One such sparse study where miRNA‐functionalized‐silk was used for orthopedic research was conducted by James et al. 184 Here, they developed an all‐aqueous, silk‐based device to enhance the osteoinduction of MSCs. Just by simply doping the silk fibroin solution blended with anti‐sense miR‐214 (ASmiR‐214) on the surface of the silk‐based screw, the continuous release of miRNA that inhibits the expression of osteoinductive antagonists could be detected up to 7 days. The in vitro evaluations demonstrated that the osteoblastic commitment and osseous integration were enhanced.
2.3.3. Microfluidics using silk
Recently, lab‐on‐chip approaches were followed for the production of nano‐particles of silk and nano‐films (Figure 3C). 185 , 186 Also, bioinks for the usage in 3D printing engineering have been developed. 187 , 188 Jeon et al. for instance, investigated on silk‐elastin‐like protein (SELP) polymers that can be used for predicted drug release depots. 189 Peng et al. mimicked the complex interplay of different silk glands of spiders as a “spider‐on‐chip” approach. 190 Silk in general seems to be very advantageous for the usage of lab‐on‐chip devices compared to other materials such as ceramics and polymers. 191 , 192 This is specifically true if advantage is taken of hydrophilic or hydrophobic yarns with high elasticity. 191 , 193 , 194
3. SILK USED FOR INTERVERTEBRAL DISC REPAIR
Regarding the silk's biomechanical properties and its versatile biomedical applications, this biomaterial has also been considered and used for IVD research with the aim to repair damaged and/or degenerated IVDs. 23 Anatomically spoken, there are two approaches how to repair the IVD using silk; either by targeting the NP or the AF.
3.1. Nucleus pulposus repair
In the past, the NP has been a popular target to repair a degenerated IVD. This is likely related to the fact that IDD has its origins in the NP, where a reduced ECM turnover accompanied by a loss of internal proteoglycans leads to the disc's dehydration. 11 Most NP replacement biomaterials, made at least partially of silk, are hydrogels. This seems like the most obvious choice since hydrogels and the NP both share a lot of common ground. Hydrogels can absorb significant amounts of liquid, and they can be designed to have similar mechanobiological properties as the highly hydrated NP. 195 , 196 , 197
One of the first approaches to use a hydrogel with incorporated silk to regenerate NP tissue was carried out by Park et al. 198 Their approach was to encapsulate chondrocytes with a hydrogel that consisted of fibrin/hyaluronic acid (HA) only, 2% silk or a combination of both biomaterials either with 1%, 1.5%, or 2% silk. They supplemented silk to the fibrin/HA hydrogel to achieve superior mechanical strength compared to plain fibrin/HA gels. After 1 week of culture, all five groups showed a defined chondrogenic area stained with alcian blue. Furthermore, all silk groups expressed a significantly higher GAG content than the fibrin/HA only group after 1 week. However, based on the gene expression of COL2, SOX9, and ACAN, the 2% silk gel and the 2% hybrid were inferior to the other groups. Interesting results were also found regarding the mechanical properties of the different gels. As hypothesized, all samples treated with silk presented a significantly higher compressive modulus and yield strength than those without silk, making them a better substitute for NP tissue.
Recently, a similar approach has been carried out that also explored the influence of silk/HA‐composite hydrogel concentrations on the samples' biomechanical behavior. 199 This study confirmed the correlation between higher silk to hyaluronic acid ratio and a higher viscoelastic modulus. Furthermore, in combination with TGF‐β3 enriched chondrogenic inductive medium, the hydrogels promoted considerable NP‐like differentiation of bone marrow‐derived MSCs after only 7 days. This differentiation was most clearly noticeable through a significantly enhanced expression of GAG and COL2 in the ECM and a significantly higher gene expression of ACAN and COL2.
Another study on silk‐based hydrogels was conducted by Hu et al. 200 Here, they were working on an injectable hydrogel with the ultimate goal of replacing a degenerated NP. They proposed a crosslinked hydrogel composed of silk fibroin and polyurethane, which could be prepared in a liquid or semi‐liquid state at room temperature. The hydrogel showed great cytocompatible properties during a one‐week culture period using bone marrow‐derived MSCs, good radiographical visibility and a Young's modulus comparable to that of a natural NP. In a follow‐up study, the group further focused on the mechanical features of the same hydrogel as well as its in vivo biocompatibility. 201 Confined compression and fatigue tests revealed adequate physical‐mechanical characteristics and the ability to withstand a million cycles at an axial strain of 15% and a frequency of 5 Hz. The hydrogel's biocompatibility was shown with an in vivo rabbit model, where they transplanted the dried implants into the paravertebral muscle. After 3 months, no inflammatory response was observed in the surrounding tissue, nor did the hydrogel display any apparent signs of deformation or degradation. In conclusion, the investigators state that due to the good biomechanical properties, which resemble those of a healthy NP, further animal trials and, ultimately, its clinical transition seems realistic.
The wide range of possible applications of silk fibroin for the regeneration of the NP was nicely shown by Murab et al. 202 Not only was the silk used as a hydrogel for improved mechanical support, but within the hydrogel, silk fibroin was shaped into hollow microspheres and used as carriers for N‐acetyl‐D‐glucosamine (GlcNAc). As GlcNAc has been known to regulate the expression of TGF‐β1 203 and for the formation of large proteoglycan aggregates, 204 it was hypothesized that its spatiotemporal release would enhance the differentiation of human adipose‐derived stem cells towards a NP‐like phenotype. Indeed, cells cultured in hydrogels containing GlcNAc‐loaded microspheres expressed significantly more COL2 and ACAN than controls lacking GlcNAc. Furthermore, the hydrogel's rheological characterization demonstrated its injectability, and cyclic compressive testing using degenerated IVDs with subsequent hydrogel injection revealed a compressive strength similar to that of a healthy IVD.
Almost all trials that aimed to regenerate/repair the NP with silk used such from the silkworm B. mori. In this context, only a single study has assessed how non‐mulberry silk could be used for NP regeneration. 196 Here, composite hydrogels were formed using different ratios of silk fibroin proteins derived from Antheraea assamensis and B. mori. The aim was then to find a suitable mixture of these two silk fibroins for in situ replacement of the NP. After testing different ratios of silk fibroin blends, the investigators observed that the higher the concentration of Antheraea assamensis derived silk, the faster the hydrogel's gelation, but also degradation time, the higher the proliferation rate of NP cells and the greater its ability to swell as well as to withstand cyclic compression. In conclusion, they state that the hydrogel's properties can be adjusted by varying the silk fibroin proportions, making it a potential candidate for clinical translation.
Nevertheless, despite the promising results obtained with hydrogels for NP repair, they also have their limitations. Due to their viscous nature, cell migration and the exchange of nutrients and waste products into and out of the hydrogel can be hindered, and the synthesis of newly formed ECM can be impaired. 205 , 206 To tackle these issues, Zeng et al. created a highly porous silk fibroin scaffold with interconnected macropores, leaving enough space for NP cells to infiltrate, increase, and to deposit newly synthesized ECM. 206 As hypothesized, NP cells infiltrated the scaffolds and proliferated well therein, as a significant increase in DNA content was found over a culture period of 3 weeks. Moreover, quantitative analysis showed that significantly more COL2 and proteoglycans were deposited on the scaffold after 3 weeks of culture, which then further improved the compressive elastic modulus of the scaffold itself.
A summary of published articles concerning the application of silk‐based biomaterials for the repair and regeneration of the NP can be found in Table 3.
TABLE 3.
Overview of published studies where silk was used to repair/regenerate the nucleus pulposus
| Silk origin | Silk structure | Study | Conclusions | References |
|---|---|---|---|---|
| Bombyx mori | Hydrogel | Assess whether a composite hydrogel made of silk‐fibrin and hyaluronic acid causes greater mechanical strength and more chondrogenesis than silk‐fibrin/hyaluronic acid alone. | Silk‐fibrin/hyaluronic acid hydrogels had improved mechanical strength and a decreased degradation rate while maintaining the chondrogenic phenotype of NP cells. | 198 |
| Bombyx mori | Hydrogel | Comparing the mechanical properties and chondrogenic inductive potential of hydrogels made of hyaluronic acid and different silk fibroin strains with varying weight ratios. | The higher the weight ratio of silk fibroin to hyaluronic acid, the greater the viscoelastic modulus. Moreover, the hydrogels promoted NP‐like differentiation of MSCs. | 199 |
| N/A | Hydrogel | Testing the biomechanical properties of a NP replacement hydrogel consisting of silk fibroin and polyurethane. | The hydrogel possessed adequate physical‐mechanical properties to replace the NP as a prosthetic biomaterial. | 200 |
| N/A | Hydrogel | Determine the compressive mechanic characteristics, stability and biocompatibility of a composite hydrogel made of silk fibroin and polyurethane in vivo. | The hydrogel showed great biocompatibility in vivo and no obvious signs of degradation were found after 3 months of implantation. | 201 |
| Bombyx mori | Cryogel | Assess the effect of a silk fibroin enriched poly (vinyl) alcohol cryogel on its hydrophilicity and how it influences the cellular attachment and proliferation of adipose‐derived MSCs. | The enrichment of silk improved the cryogels' rehydration ratio, water content, hoop stress, and compressive modulus. Moreover, cell‐hosting abilities were improved. | 248 |
| Bombyx mori | Hydrogel | Creating a hydrogel that resembles the NP's ECM. The hydrogel was chitosan and COL2 based and to increase the hydrophilicity and stability, gelatin and silk fibroin were added. | The hydrogel was injectable at 4°C and started gelation after 30 min at 37°C. The addition of silk increased the hydrogel's stability and durability. | 249 |
| Bombyx mori | Silk microspheres embedded in a silk hydrogel | Study the effect of GlcNAc loaded hollow spheres on the NP‐like differentiation of adipose‐derived MSCs, which are embedded in silk fibroin together with the spheres. | Spatiotemporally controlled release of GlcNAc enhanced the expression of COL2, ACAN and GAG. Furthermore, the hydrogel brought adequate structural support during cyclic compression. | 202 |
| Bombyx mori and Antheraea assamensis | Hydrogel | Blending two different silk variations to design a suitable hydrogel for in situ NP replacement applications. | The gelation time and mechanical properties of the hydrogel could be tuned depending on the ratio of the silk variants. NP cells proliferated on all variants tested. | 196 |
| Bombyx mori | Scaffold | Determine the feasibility of porous silk fibroin scaffolds seeded with NP cells for NP regeneration. | NP cells proliferated in the scaffold and produced significant amounts of COL2 and proteoglycans. A higher cell number resulted in a greater compressive elastic modulus of the scaffold. | 206 |
Abbreviations: ACAN, aggrecan; COL2, collagen type II; ECM, extracellular matrix; GAG, glycosaminoglycan; GlcNAc, N‐acetyl‐glucasamine; MSC, mesenchymal stromal cell; NP, nucleus pulposus; N/A, non‐available.
3.2. Annulus fibrosus repair
Just as hydrogels have been used almost exclusively for the repair/regeneration of the NP, only firm scaffolds can be found for the application of the AF. Early investigations on how to implement silk specifically for the repair or regeneration of the AF were done by Park et al. 207 , 208 In two related studies, silk scaffolds with a lamellar morphology were compared to ones with a porous, spongy structure. The aim was to find out whether an AF‐like lamellar structure would positively influence the tissue formation of porcine AF cells. Both studies concluded that the lamellar orientation of the scaffolds improved the construction of AF‐like tissue during a culture period of 2 weeks. Furthermore, compared to the porous scaffolds, the amount of GAG gradually and significantly increased in the lamellar samples, and significantly more collagen was detected towards the end of each experiment. Surprisingly, however, the porous scaffold displayed a superior elastic modulus and tensile strength after 1 day of culture but then showed comparable values after 2 weeks.
Around the same time, See et al. worked on silk scaffolds for AF regeneration. In a first attempt, cell sheets consisting of bone‐marrow‐derived MSCs were transferred onto a porous silk scaffold and wrapped around an artificial NP made of silicone. 209 The IVD‐like assembly was then cultured for 4 weeks under static conditions. During this culture period, the cell activity remained unchanged, and the cell sheets' initial COL1‐rich ECM shifted towards a COL2‐dominant environment, resembling the ECM found in the inner AF. The same construct was then used in a follow‐up study, but this time they cultured it in a bioreactor that enabled dynamic compressional loading. 210 Results revealed that, on the one hand, the MSCs' metabolic activity decreased significantly after 4 weeks of culture compared to the static load. On the other hand, dynamic loading improved the gene expression profile of the MSCs that were seeded onto the scaffold, as essential IVD‐related genes such as SOX9, COL1, COL2, ACAN, and biglycan were significantly higher expressed than in the static condition. Since then, multiple studies have attempted to mimic the AF's anatomical structure using a silk scaffold, and they all share the same conclusion: The more precisely the scaffold can replicate the human AF, the better the phenotype of the cultured cells and the closer the mechanical properties of the scaffold compared to native AF tissue. 211 , 212
Although the morphology of the scaffold has a crucial impact on the synthesis of AF‐like tissue, the composition and the properties of the biomaterial itself are also known to be just as ground‐breaking for successful tissue formation. The surface of silk fibroin can be functionalized by covalent conjugation of biomolecules, thereby making its features tuneable and consequently allowing a more efficient and better‐defined differentiation or retention of an AF‐like phenotype. 213 For example, RGD functionalization of silk fibroin scaffolds has shown to enhance the expression of ACAN and COL2 in AF cells compared to the nonmodified silk. 214 Another example would be the application of genetically engineered silk that was functionalized either with TGF‐β3 or growth and differentiation factor 6 (GDF‐6) and was able to preserve the phenotype of human AF cells (Figure 3). 215 Ideally, however, surface functionalization is combined with a suitable scaffold that tries to imitate the structure of the AF as closely as possible. The functionalization was nicely illustrated in a series of studies by Bhattacharjee et al. 216 , 217 , 218 Here, silk fibroin fibers were functionalized with chondroitin sulfate (CS) and were aligned in a crisscross orientated manner to resemble the AF. Although first attempts could not reveal any notable differences between the functionalized and the plain scaffold, 216 a refined setup using articular chondrocytes instead of nasal chondrocytes led to an upregulation of SOX9, ACAN, and biglycan, an improved production of GAG and collagens, an eminent increase of the metabolic activity and a significantly higher compressive strength with the CS‐treated scaffolds compared to controls. 217 However, the full potential of their functionalized scaffold was achieved when the scaffolds were cultured in a hydrodynamic environment and a distinction was made between inner and outer AF. 218 Previous studies had shown that the presence of CS can cause MSCs to adopt a phenotype comparable to that of inner AF cells. 219 , 220 Consequently, only the inner part of the scaffold was functionalized with CS. With this study design, they demonstrated that the dynamic culture conditions enhanced the metabolic activity and the production of ECM. Furthermore, due to the CS in the inner AF, a chondrogenic tissue gradient was formed, with the inner part expressing significantly more COL2, ACAN, biglycan and significantly less COL1 and elastin than the outer part of the scaffold, thereby mimicking the properties of native AF tissue.
A relatively recent and very ambitious study on the use of anatomically‐shaped silk scaffolds for the regeneration of the AF was conducted by Costa et al. 221 Therefore, a reverse engineering approach was followed in which a human patient was subjected to an MRI scan and then, based on the segmented morphologic scan of the L1‐L2 IVD, a 3D model of the AF's ultrastructure was printed with a bioink made of SF and elastin. Remarkably, the mechanical characteristics, including the compressive modulus and stress–strain‐curve, turned out to be very similar to those of fibrocartilage cartilage tissue found in the AF. 221 Moreover, human adipose‐derived stem cells adhered well onto the scaffold and remained metabolically active for 21 days.
Finally, it is important to point out that silk scaffolds or scaffolds in general do not always have to be the basis for novel tissue formation and as a result aim to replace the defective or degenerative tissue itself. Still, they can be also used specifically to support the reparative process of a defective site. A corresponding example of this is provided by Frauchiger et al. using a bovine IVD damage model. 222 Here, an AF defect was induced with a biopsy punch and the created cavity was subsequently filled with a genipin‐enhanced fibrin hydrogel, sealed with a silk fibroin scaffold and then the entire IVD was tested under different culture/loading regimes. Even though the IVDs' height could not be recovered, the silk scaffold reliably sealed the repaired site, as no herniation of the hydrogel could be detected during extensive dynamic loading.
A summary of published articles concerning the application of silk‐based biomaterials for the regeneration and repair of the AF can be found in Table 4.
TABLE 4.
Overview of published studies where silk was used to repair/regenerate the annulus fibrosus
| Silk origin | Silk structure | Study | Conclusions | References |
|---|---|---|---|---|
| Bombyx mori | Scaffold | Assess whether either lamellar or porous spongy silk scaffolds are better suited for AF tissue formation and function. Both scaffolds were seeded with porcine AF cells. | Both scaffolds showed similar mechanical properties after 2 weeks of culture. However, lamellar scaffolds enabled a significantly higher GAG and collagen production than porous scaffolds. | 207 |
| Bombyx mori | Scaffold | Creating a biphasic structure that mimics the IVD. The AF‐like structure was made of silk and was cultured with porcine AF cells and the NP scaffold consisted of fibrin and hyaluronic acid and was cultured with porcine chondrocytes. | The amount of GAG significantly increased with the lamellar AF scaffolds during a culture period of 4 weeks. Lamellar NP scaffolds showed significantly more collagen after 2 weeks and more GAG after 4 weeks. | 208 |
| Bombyx mori | Scaffold | Assess whether porous silk scaffolds with or without RGD allow AF cells to attach and promote ECM production. | AF cells attached and proliferated on the scaffold regardless of whether the silk was functionalized with RGD or not. However, RGD silk improved ACAN and COL2 expression. | 214 |
| N/A | Scaffold | Integrating MSC‐sheets onto silk scaffolds that were wrapped around a disc made of silicon. The artificial IVD was cultured for 4 weeks in static conditions. | MSCs‐sheets adhered well to the silk scaffolds. During a culture period of 4 weeks, MSCs remained metabolically active and the COL2 to COL1 ratio increased over time. | 209 |
| N/A | Scaffold | Using alternating layers of silk scaffolds that were wrapped around a silicon disc to simulate and IVD‐like assembly. MSC‐sheets were put onto the scaffolds and the construct was mechanically stimulated. | Cells remained viable over a culture period of 4 weeks, however, the viability gradually decreased. Mechanical stimulation guided the MSCs to differentiate towards a phenotype that resembles the inner AF. | 210 |
| Bombyx mori | Scaffold | A multilayered, angle‐ply scaffold was created to mimic the anatomical structure of the AF. Porcine AF cells or human MSCs were seeded onto the scaffold. | AF cells and MSCs proliferated during 14 days of culture and produced significant amounts of ECM. The scaffolds also displayed good mechanical properties. | 211 |
| N/A | Scaffold | Creating a biomimetic multilamellar angle‐ply AF‐like scaffold made of polycaprolactone and silk fibroin fibers with ±30° alternating orientation. Leporine AF cells were seeded onto the scaffold. | The AF‐like scaffolds possessed mechanical properties similar to those of a natural AF. AF cells managed to adhere, proliferate, infiltrate into the scaffold and deposited ECM. | 212 |
| Antheraea mylitta | Scaffold | Creating a silk fibroin scaffold using crisscross‐oriented fibers to mimic the structure of a native AF tissue. Fibers were made with or without crosslinked CS. | Nasal chondrocytes aligned along the silk fibers and produced GAG and COL2 after 4 weeks of culture, regardless of the presence of CS. | 216 |
| Antheraea mylitta | Scaffold | Study the cellular response of CS functionalized silk scaffolds using articular chondrocytes. | Chondrocytes showed enhanced chondrogenic redifferentiation potential and a higher metabolic activity in the presence of CS functionalized silk. | 217 |
| Antheraea mylitta | Scaffold | Mimicking the inner and outer AF using crisscross‐orientated silk fibers and articular chondrocytes. The fibers of the inner AF were functionalized with CS. The scaffolds were loaded statically and dynamically. | A tissue gradient was formed that mimicked the characteristics of the inner and outer AF. Cells in the inner AF produced more GAG and expressed more COL2 and ACAN, whereas more COL1 was found in the outer AF. | 218 |
| Bombyx mori | Scaffold | 3D printing of an anatomically‐shaped AF using a composite bioink made of silk fibroin and elastin. Adipose derived stem cells were used to test the scaffold's cytocompatibility. | The bioprinted scaffolds morphologically resembled an anatomically‐shaped AF and displayed mechanical characteristics similar to a native AF. Moreover, cells were metabolically active for 21 days. | 221 |
| Bombyx mori | Scaffold | Assess how well genetically engineered silk containing TGF‐β3 or GDF‐6 promotes IVD‐like differentiation of MSCs and how well it maintains the phenotype of AF cells. | MSCs expressed about 10 times more ACAN than COL2, indicating a trend towards NP‐like differentiation. AF cells were not negatively affected by the silk. | 215 |
| Bombyx mori | Scaffold | An AF injury was induced in bovine IVDs. To repair the IVD, the created cavity was filled with a genipin‐enhanced fibrin hydrogel and sealed with a silk scaffold. Then, the IVDs were mechanically tested. | The repair was considered as a success because no herniation occurred regardless of the loading condition. However, the IVDs' height could not be recovered. | 222 |
Abbreviations: ACAN, aggrecan; AF, annulus fibrosus; CS, chondroitin sulfate; COL1, collagen type I; COL2, collagen type II; ECM, extracellular matrix; GAG, glycosaminoglycan; GDF‐6, growth and differentiation factor 6; IVD, intervertebral disc; MSC, mesenchymal stromal cell; NP, nucleus pulposus; RGD, arginine‐glycine‐aspartic acid; TGF‐β3, transforming growth factor β3; N/A, non‐available.
4. CONCLUSION
Humans have bred silkworms for centuries, and their silk has found many uses thanks to its excellent biomechanical properties. There are many different species from which silk can be harvested, and each has its characteristics, advantages, and disadvantages. However, the clear dominator on the market is SF, derived from the silkworm B. mori.
In the clinic nowadays, silk is mainly used for surgical sutures. However, many preclinical studies show its great potential and versatility as a tissue repair and regenerative biomaterial. Especially in the past decade, the application of silk has also found its way into the field of IVD‐related research, where mainly silk‐based hydrogels have been used for the regeneration of the NP and only firm silk‐based scaffolds have been investigated for the repair of the AF. Some of these scaffolds and hydrogels show auspicious outcomes. They thus indicate a transition into clinics in the foreseeable future, where they will hopefully present themselves as another missing puzzle piece to treat and ultimately cure patients suffering from IDD.
AUTHOR CONTRIBUTIONS
The study conception and design were proposed by Andreas S. Croft and Benjamin Gantenbein. The literature search and data analysis were done by Andreas S. Croft, Eugenia Spessot, Promita Bhattacharjee, and Yuejiao Yang. Benjamin Gantenbein, Promita Bhattacharjee and Eugenia Spessot designed the figure arts. The initial draft of the manuscript was written by Andreas S. Croft, Eugenia Spessot, Promita Bhattacharjee, and Yuejiao Yang and was then reviewed and edited by Antonella Motta, Michael Wöltje, and Benjamin Gantenbein. Funding was provided by Benjamin Gantenbein, Antonella Motta and Michael Wöltje.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
ACKNOWLEDGMENTS
This study was supported by the Swiss National Science Foundation # 310030E_192674/1, by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation #437213841) and by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement No 778078, the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement No 101008041, and Fondazione Caritro (Italy) with the project “One‐step 3D bioprinting and in vitro validation of a full thickness corneal tissue.”
Croft, A. S. , Spessot, E. , Bhattacharjee, P. , Yang, Y. , Motta, A. , Wöltje, M. , & Gantenbein, B. (2022). Biomedical applications of silk and its role for intervertebral disc repair. JOR Spine, 5(4), e1225. 10.1002/jsp2.1225
Funding information Deutsche Forschungsgemeinschaft, Grant/Award Number: #437213841; Fondazione Caritro; H2020 Marie Skłodowska‐Curie Actions, Grant/Award Numbers: 101008041, 778078; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Grant/Award Number: 310030E_192674/1
REFERENCES
- 1. Ravindra VM, Senglaub SS, Rattani A, et al. Degenerative lumbar spine disease: estimating global incidence and worldwide volume. Global Spine J. 2018;8(8):784‐794. doi: 10.1177/2192568218770769 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Cheung KM, Karppinen J, Chan D, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty‐three individuals. Spine (Phila Pa 1976). 2009;34(9):934‐940. doi: 10.1097/BRS.0b013e3181a01b3f [DOI] [PubMed] [Google Scholar]
- 3. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. Classification of age‐related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976). 2002;27(23):2631‐2644. doi: 10.1097/00007632-200212010-00002 [DOI] [PubMed] [Google Scholar]
- 4. Kos N, Gradisnik L, Velnar T. A brief review of the degenerative intervertebral disc disease. Med Arch. 2019;73(6):421‐424. doi: 10.5455/medarh.2019.73.421-424 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Miller JA, Schmatz C, Schultz AB. Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens. Spine (Phila Pa 1976). 1988;13(2):173‐178. [PubMed] [Google Scholar]
- 6. Battie MC, Videman T, Gibbons LE, Fisher LD, Manninen H, Gill K. Volvo Award in clinical sciences. Determinants of lumbar disc degeneration. A study relating lifetime exposures and magnetic resonance imaging findings in identical twins. Spine (Phila Pa 1976). 1995;20(24):2601‐2612. [PubMed] [Google Scholar]
- 7. Kalichman L, Hunter DJ. The genetics of intervertebral disc degeneration. Familial predisposition and heritability estimation. Joint Bone Spine. 2008;75(4):383‐387. doi: 10.1016/j.jbspin.2007.11.003 [DOI] [PubMed] [Google Scholar]
- 8. Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino JA, Herzog R. ISSLS Prize Winner: does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten‐year matched cohort study. Spine (Phila Pa 1976). 2009;34(21):2338‐2345. doi: 10.1097/BRS.0b013e3181ab5432 [DOI] [PubMed] [Google Scholar]
- 9. Grunhagen T, Wilde G, Soukane DM, Shirazi‐Adl SA, Urban JP. Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am. 2006;88(Suppl 2):30‐35. doi: 10.2106/JBJS.E.01290 [DOI] [PubMed] [Google Scholar]
- 10. Vergroesen PP, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthr Cartil. 2015;23(7):1057‐1070. doi: 10.1016/j.joca.2015.03.028 [DOI] [PubMed] [Google Scholar]
- 11. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976). 2006;31(18):2151‐2161. doi: 10.1097/01.brs.0000231761.73859.2c [DOI] [PubMed] [Google Scholar]
- 12. Iatridis JC, MacLean JJ, O'Brien M, Stokes IA. Measurements of proteoglycan and water content distribution in human lumbar intervertebral discs. Spine (Phila Pa 1976). 2007;32(14):1493‐1497. doi: 10.1097/BRS.0b013e318067dd3f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Adams P, Eyre DR, Muir H. Biochemical aspects of development and ageing of human lumbar intervertebral discs. Rheumatol Rehabil. 1977;16(1):22‐29. doi: 10.1093/rheumatology/16.1.22 [DOI] [PubMed] [Google Scholar]
- 14. Galbusera F, van Rijsbergen M, Ito K, Huyghe JM, Brayda‐Bruno M, Wilke HJ. Ageing and degenerative changes of the intervertebral disc and their impact on spinal flexibility. Eur Spine J. 2014;23(Suppl 3):S324‐S332. doi: 10.1007/s00586-014-3203-4 [DOI] [PubMed] [Google Scholar]
- 15. Dowdell J, Erwin M, Choma T, Vaccaro A, Iatridis J, Cho SK. Intervertebral disk degeneration and repair. Neurosurgery. 2017;80(3S):S46‐S54. doi: 10.1093/neuros/nyw078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Ambard D, Cherblanc F. Mechanical behavior of annulus fibrosus: a microstructural model of fibers reorientation. Ann Biomed Eng. 2009;37(11):2256‐2265. doi: 10.1007/s10439-009-9761-7 [DOI] [PubMed] [Google Scholar]
- 17. Martin MD, Boxell CM, Malone DG. Pathophysiology of lumbar disc degeneration: a review of the literature. Neurosurg Focus. 2002;13(2):E1‐E6. doi: 10.3171/foc.2002.13.2.2 [DOI] [PubMed] [Google Scholar]
- 18. Sampara P, Banala RR, Vemuri SK, Av GR, Gpv S. Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review. Gene Ther. 2018;25(2):67‐82. doi: 10.1038/s41434-018-0004-0 [DOI] [PubMed] [Google Scholar]
- 19. Bowles RD, Setton LA. Biomaterials for intervertebral disc regeneration and repair. Biomaterials. 2017;129:54‐67. doi: 10.1016/j.biomaterials.2017.03.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Vernengo A, Li Z, Grad S. Editorial – disc biology special issue. Eur Cell Mater. 2022;43:1‐3. doi: 10.22203/eCM.v043a01 [DOI] [PubMed] [Google Scholar]
- 21. Yamada K, Iwasaki N, Sudo H. Biomaterials and cell‐based regenerative therapies for intervertebral disc degeneration with a focus on biological and biomechanical functional repair: targeting treatments for disc herniation. Cell. 2022;11(4):602. doi: 10.3390/cells11040602 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Altman GH, Diaz F, Jakuba C, et al. Silk‐based biomaterials. Biomaterials. 2003;24(3):401‐416. doi: 10.1016/s0142-9612(02)00353-8 [DOI] [PubMed] [Google Scholar]
- 23. Frauchiger DA, Tekari A, Woltje M, Fortunato G, Benneker LM, Gantenbein B. A review of the application of reinforced hydrogels and silk as biomaterials for intervertebral disc repair. Eur Cell Mater. 2017;34:271‐290. doi: 10.22203/eCM.v034a17 [DOI] [PubMed] [Google Scholar]
- 24. Collin MA, Mita K, Sehnal F, Hayashi CY. Molecular evolution of lepidopteran silk proteins: insights from the ghost moth, Hepialus californicus . J Mol Evol. 2010;70(5):519‐529. doi: 10.1007/s00239-010-9349-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Mariano‐Martins P, Monfardini RD, Lo‐Man‐Hung N, Torres TT. Evidence of positive selection on six spider developmental genes. J Exp Zool B Mol Dev Evol. 2022;338:314‐322. doi: 10.1002/jez.b.23119 [DOI] [PubMed] [Google Scholar]
- 26. Arakawa K, Mori M, Kono N, Suzuki T, Gotoh T, Shimano S. Proteomic evidence for the silk fibroin genes of spider mites (order Trombidiformes: family Tetranychidae). J Proteomics. 2021;239:104195. doi: 10.1016/j.jprot.2021.104195 [DOI] [PubMed] [Google Scholar]
- 27. Fraser RDB, Parry DAD. The molecular structure of the silk fibers from Hymenoptera aculeata (bees, wasps, ants). J Struct Biol. 2015;192(3):528‐538. doi: 10.1016/j.jsb.2015.10.017 [DOI] [PubMed] [Google Scholar]
- 28. Melesse G, Atalie D, Koyrita A. Structural and thermal properties of Ethiopian Eri and Mulberry silk fibres. Adv Mater Sci Eng. 2020;2020:9750393. doi: 10.1155/2020/9750393 [DOI] [Google Scholar]
- 29. Mazzi S, Zulker E, Buchicchio J, Anderson B, Hu X. Comparative thermal analysis of Eri, Mori, Muga, and Tussar silk cocoons and fibroin fibers. J Therm Anal Calorim. 2014;116(3):1337‐1343. doi: 10.1007/s10973-013-3631-0 [DOI] [Google Scholar]
- 30. Rising A, Nimmervoll H, Grip S, et al. Spider silk proteins—mechanical property and gene sequence. Zoolog Sci. 2005;22(3):273‐281. doi: 10.2108/zsj.22.273 [DOI] [PubMed] [Google Scholar]
- 31. Scheller J, Guhrs KH, Grosse F, Conrad U. Production of spider silk proteins in tobacco and potato. Nat Biotechnol. 2001;19(6):573‐577. doi: 10.1038/89335 [DOI] [PubMed] [Google Scholar]
- 32. Holland C, Numata K, Rnjak‐Kovacina J, Seib FP. The biomedical use of silk: past, present, future. Adv Healthc Mater. 2019;8(1):e1800465. doi: 10.1002/adhm.201800465 [DOI] [PubMed] [Google Scholar]
- 33. Neubauer VJ, Dobl A, Scheibel T. Silk‐based materials for hard tissue engineering. Materials (Basel). 2021;14(3):674. doi: 10.3390/ma14030674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Jao D, Mou X, Hu X. Tissue regeneration: a silk road. J Funct Biomater. 2016;7(3):22. doi: 10.3390/jfb7030022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Aksakal B, Akdere Ü, Günay SD, Çağın T, Taşseven Ç. Influence of repeating sequence on structural and thermal stability of crystalline domain of bombyx mori silk fibroin. Mater Res Express. 2020;6(12):125356. doi: 10.1088/2053-1591/ab6548 [DOI] [Google Scholar]
- 36. Bhattacharjee M, Schultz‐Thater E, Trella E, et al. The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk‐based biomaterials. Biomaterials. 2013;34(33):8161‐8171. doi: 10.1016/j.biomaterials.2013.07.018 [DOI] [PubMed] [Google Scholar]
- 37. Janani G, Kumar M, Chouhan D, et al. Insight into silk‐based biomaterials: from physicochemical attributes to recent biomedical applications. ACS Appl Bio Mater. 2019;2(12):5460‐5491. doi: 10.1021/acsabm.9b00576 [DOI] [PubMed] [Google Scholar]
- 38. Rossiter CH. Silk and the Silk Worm. A Complete Book of Instruction on Silk Culture. CH Rossiter; 1881. [Google Scholar]
- 39. Wei‐cheng WU, Qi‐kang GAO, Jin‐e C, et al. Analysis of two‐dimensional gel electrophoresis images of protein from posterior silk gland of silkworm (Bombyx mori) on day 1 and day 4 in the 5th instar stage. Agric Sci China. 2007;6(2):249‐254. doi: 10.1016/S1671-2927(07)60042-X [DOI] [Google Scholar]
- 40. Kundu B, Kurland NE, Bano S, et al. Silk proteins for biomedical applications: bioengineering perspectives. Prog Polym Sci. 2014;39(2):251‐267. doi: 10.1016/j.progpolymsci.2013.09.002 [DOI] [Google Scholar]
- 41. Sasaki T, Noda H. Studies on silk fibroin of Bombyx mori directly extracted from the silk gland. II. Effect of reduction of disulfide bonds and subunit structure. Biochim Biophys Acta. 1973;310(1):91‐103. doi: 10.1016/0005-2795(73)90011-1 [DOI] [PubMed] [Google Scholar]
- 42. Inoue S, Tanaka K, Arisaka F, Kimura S, Ohtomo K, Mizuno S. Silk fibroin of Bombyx mori is secreted, assembling a high molecular mass elementary unit consisting of H‐chain, L‐chain, and P25, with a 6:6:1 molar ratio. J Biol Chem. 2000;275(51):40517‐40528. doi: 10.1074/jbc.M006897200 [DOI] [PubMed] [Google Scholar]
- 43. Zafar MS, Belton DJ, Hanby B, Kaplan DL, Perry CC. Functional material features of Bombyx mori silk light versus heavy chain proteins. Biomacromolecules. 2015;16(2):606‐614. doi: 10.1021/bm501667j [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Asakura T, Yao J, Yamane T, Umemura K, Ulrich AS. Heterogeneous structure of silk fibers from Bombyx mori resolved by 13C solid‐state NMR spectroscopy. J Am Chem Soc. 2002;124(30):8794‐8795. doi: 10.1021/ja020244e [DOI] [PubMed] [Google Scholar]
- 45. Callone E, Dire S, Hu X, Motta A. Processing influence on molecular assembling and structural conformations in silk fibroin: elucidation by solid‐state NMR. ACS Biomater Sci Eng. 2016;2(5):758‐767. doi: 10.1021/acsbiomaterials.5b00507 [DOI] [PubMed] [Google Scholar]
- 46. Asakura T, Tanaka T, Tanaka R. Advanced silk fibroin biomaterials and application to small‐diameter silk vascular grafts. ACS Biomater Sci Eng. 2019;5(11):5561‐5577. doi: 10.1021/acsbiomaterials.8b01482 [DOI] [PubMed] [Google Scholar]
- 47. Asakura T, Aoki A, Komatsu K, et al. Lamellar structure in alanine‐glycine copolypeptides studied by solid‐state NMR spectroscopy: a model for the crystalline domain of Bombyx mori silk fibroin in silk II form. Biomacromolecules. 2020;21(8):3102‐3111. doi: 10.1021/acs.biomac.0c00486 [DOI] [PubMed] [Google Scholar]
- 48. Cheng Y, Koh LD, Li D, Ji B, Han MY, Zhang YW. On the strength of beta‐sheet crystallites of Bombyx mori silk fibroin. J R Soc Interface. 2014;11(96):20140305. doi: 10.1098/rsif.2014.0305 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Kunz RI, Brancalhao RM, Ribeiro LF, Natali MR. Silkworm Sericin: properties and biomedical applications. Biomed Res Int. 2016;2016:8175701. doi: 10.1155/2016/8175701 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Omar A, Gao Y, Wubulikasimu A, Arken A, Aisa HA, Yili A. Effects of trypsin‐induced limited hydrolysis on the structural, functional, and bioactive properties of sericin. RSC Adv. 2021;11(41):25431‐25440. doi: 10.1039/D1RA03772B [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Das G, Shin HS, Campos EVR, et al. Sericin based nanoformulations: a comprehensive review on molecular mechanisms of interaction with organisms to biological applications. J Nanobiotechnol. 2021;19(1):30. doi: 10.1186/s12951-021-00774-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Cherdchom S, Sereemaspun A, Aramwit P. Urea‐extracted sericin is potentially better than kojic acid in the inhibition of melanogenesis through increased reactive oxygen species generation. J Tradit Complement Med. 2021;11(6):570‐580. doi: 10.1016/j.jtcme.2021.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Silva VR, Ribani M, Gimenes ML, Scheer AP. High molecular weight Sericin obtained by high temperature and ultrafiltration process. Proc Eng. 2012;42:833‐841. doi: 10.1016/j.proeng.2012.07.476 [DOI] [Google Scholar]
- 54. Aramwit P, Siritientong T, Srichana T. Potential applications of silk sericin, a natural protein from textile industry by‐products. Waste Manag Res. 2012;30(3):217‐224. doi: 10.1177/0734242X11404733 [DOI] [PubMed] [Google Scholar]
- 55. Chirila TV, Suzuki S, McKirdy NC. Further development of silk sericin as a biomaterial: comparative investigation of the procedures for its isolation from Bombyx mori silk cocoons. Prog Biomater. 2016;5:135‐145. doi: 10.1007/s40204-016-0052-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Jaramillo‐Quiceno N, Callone E, Dirè S, Álvarez‐López C, Motta A. Boosting sericin extraction through alternative silk sources. Polym J. 2021;53(12):1425‐1437. doi: 10.1038/s41428-021-00539-2 [DOI] [Google Scholar]
- 57. Woltje M, Kolbel A, Aibibu D, Cherif C. A fast and reliable process to fabricate regenerated silk fibroin solution from degummed silk in 4 hours. Int J Mol Sci. 2021;22(19):10565. doi: 10.3390/ijms221910565 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Zurovec M, Yang C, Kodrik D, Sehnal F. Identification of a novel type of silk protein and regulation of its expression. J Biol Chem. 1998;273(25):15423‐15428. doi: 10.1074/jbc.273.25.15423 [DOI] [PubMed] [Google Scholar]
- 59. Nirmala X, Mita K, Vanisree V, Zurovec M, Sehnal F. Identification of four small molecular mass proteins in the silk of Bombyx mori . Insect Mol Biol. 2001;10(5):437‐445. doi: 10.1046/j.0962-1075.2001.00282.x [DOI] [PubMed] [Google Scholar]
- 60. Kundu SC, Kundu B, Talukdar S, et al. Invited review nonmulberry silk biopolymers. Biopolymers. 2012;97(6):455‐467. doi: 10.1002/bip.22024 [DOI] [PubMed] [Google Scholar]
- 61. Fang G, Sapru S, Behera S, et al. Exploration of the tight structural–mechanical relationship in mulberry and non‐mulberry silkworm silks. J Mater Chem B. 2016;4(24):4337‐4347. doi: 10.1039/c6tb01049k [DOI] [PubMed] [Google Scholar]
- 62. Naskar D, Sapru S, Ghosh AK, Reis RL, Dey T, Kundu SC. Nonmulberry silk proteins: multipurpose ingredient in bio‐functional assembly. Biomed Mater. 2021;16(6):062002. doi: 10.1088/1748-605X/ac20a0 [DOI] [PubMed] [Google Scholar]
- 63. Guo C, Zhang J, Jordan JS, Wang X, Henning RW, Yarger JL. Structural comparison of various silkworm silks: an insight into the structure‐property relationship. Biomacromolecules. 2018;19(3):906‐917. doi: 10.1021/acs.biomac.7b01687 [DOI] [PubMed] [Google Scholar]
- 64. Tsubota T, Yamamoto K, Mita K, Sezutsu H. Gene expression analysis in the larval silk gland of the eri silkworm Samia ricini . Insect Sci. 2016;23(6):791‐804. doi: 10.1111/1744-7917.12251 [DOI] [PubMed] [Google Scholar]
- 65. Guo Y, Li X, Zhang Q, Yan S, You R. Dissolution and regeneration of non‐mulberry Eriogyna Pyretorum silk fibroin. Mater Res Express. 2017;4(10):105404. doi: 10.1088/2053-1591/aa8e07 [DOI] [Google Scholar]
- 66. Silva SS, Gomes JM, Vale AC, Lu S, Reis RL, Kundu SC. Green pathway for processing non‐mulberry Antheraea pernyi silk fibroin/chitin‐based sponges: biophysical and biochemical characterization. original research. Front Mater. 2020;7:135. doi: 10.3389/fmats.2020.00135 [DOI] [Google Scholar]
- 67. Balan KK, Sundaramoorthy S. Hydroentangled nonwoven eri silk fibroin scaffold for tissue engineering applications. J Ind Text. 2018;48(8):1291‐1309. doi: 10.1177/1528083718763779 [DOI] [Google Scholar]
- 68. Mandal BB, Kundu SC. A novel method for dissolution and stabilization of non‐mulberry silk gland protein fibroin using anionic surfactant sodium dodecyl sulfate. Biotechnol Bioeng. 2008;99(6):1482‐1489. doi: 10.1002/bit.21699 [DOI] [PubMed] [Google Scholar]
- 69. Catherine ES, Alissa GA, Maydianne CBA. A review of the mechanisms and functional roles of male silk use in spider courtship and mating. J Arachnol. 2018;46(2):173‐206. doi: 10.1636/JoA-S-17-093.1 [DOI] [Google Scholar]
- 70. Morley EL, Robert D. Electric fields elicit ballooning in spiders. Curr Biol. 2018;28(14):2324‐2330 e2. doi: 10.1016/j.cub.2018.05.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Greco G, Pugno NM. How spiders hunt heavy prey: the tangle web as a pulley and spider's lifting mechanics observed and quantified in the laboratory. J R Soc Interface. 2021;18(175):20200907. doi: 10.1098/rsif.2020.0907 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Romer L, Scheibel T. The elaborate structure of spider silk: structure and function of a natural high performance fiber. Prion. 2008;2(4):154‐161. doi: 10.4161/pri.2.4.7490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Greco G, Pantano MF, Mazzolai B, Pugno NM. Imaging and mechanical characterization of different junctions in spider orb webs. Sci Rep. 2019;9(1):5776. doi: 10.1038/s41598-019-42070-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Eberhard W. Spider Webs: Behavior, Function, and Evolution. University of Chicago Press; 2020. [Google Scholar]
- 75. Eisoldt L, Smith A, Scheibel T. Decoding the secrets of spider silk. Mater Today. 2011;14(3):80‐86. doi: 10.1016/S1369-7021(11)70057-8 [DOI] [Google Scholar]
- 76. Brown CP, Rosei F, Traversa E, Licoccia S. Spider silk as a load bearing biomaterial: tailoring mechanical properties via structural modifications. Nanoscale. 2011;3(3):870‐876. doi: 10.1039/c0nr00752h [DOI] [PubMed] [Google Scholar]
- 77. Kiseleva AP, Krivoshapkin PV, Krivoshapkina EF. Recent advances in development of functional spider silk‐based hybrid materials. Front Chem. 2020;8:554. doi: 10.3389/fchem.2020.00554 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Blackledge TA. Spider silk: a brief review and prospectus on research linking biomechanics and ecology in draglines and orb webs. J Arachnol. 2012;40(1):1‐12. [Google Scholar]
- 79. Greco G, Francis J, Arndt T, et al. Properties of biomimetic artificial spider silk fibers tuned by PostSpin bath incubation. Molecules. 2020;25(14):3248. doi: 10.3390/molecules25143248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Vepari C, Kaplan DL. Silk as a biomaterial. Prog Polym Sci. 2007;32(8–9):991‐1007. doi: 10.1016/j.progpolymsci.2007.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Yarger JL, Cherry BR, van der Vaart A. Uncovering the structure–function relationship in spider silk. Nat Rev Mater. 2018;3(3):18008. doi: 10.1038/natrevmats.2018.8 [DOI] [Google Scholar]
- 82. Lewis RV. Spider silk: ancient ideas for new biomaterials. Chem Rev. 2006;106(9):3762‐3774. doi: 10.1021/cr010194g [DOI] [PubMed] [Google Scholar]
- 83. Greco G, Mastellari V, Holland C, Pugno NM. Comparing modern and classical perspectives on spider silks and webs. Perspect Sci. 2021;29(2):133‐156. doi: 10.1162/posc_a_00363 [DOI] [Google Scholar]
- 84. Scheibel T. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact. 2004;3(1):14. doi: 10.1186/1475-2859-3-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Malay AD, Arakawa K, Numata K. Analysis of repetitive amino acid motifs reveals the essential features of spider dragline silk proteins. PLoS One. 2017;12(8):e0183397. doi: 10.1371/journal.pone.0183397 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. An B, Jenkins JE, Sampath S, et al. Reproducing natural spider silks' copolymer behavior in synthetic silk mimics. Biomacromolecules. 2012;13(12):3938‐3948. doi: 10.1021/bm301110s [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Chan NJ, Gu D, Tan S, et al. Spider‐silk inspired polymeric networks by harnessing the mechanical potential of beta‐sheets through network guided assembly. Nat Commun. 2020;11(1):1630. doi: 10.1038/s41467-020-15312-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Foelix R. Biology of Spiders. 3rd ed. Oxford University Press; 2011. [Google Scholar]
- 89. Andersson M, Johansson J, Rising A. Silk spinning in silkworms and spiders. Int J Mol Sci. 2016;17(8):1290. doi: 10.3390/ijms17081290 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Johansson J, Rising A. Doing what spiders cannot‐a road map to supreme artificial silk fibers. ACS Nano. 2021;15(2):1952‐1959. doi: 10.1021/acsnano.0c08933 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Burdick JA, Mauck RL. Introduction. Biomater Tissue Eng Appl: Rev Past Future Trends. 2011;1‐564. [Google Scholar]
- 92. Sehnal F, Zurovec M. Construction of silk fiber core in lepidoptera. Biomacromolecules. 2004;5(3):666‐674. doi: 10.1021/bm0344046 [DOI] [PubMed] [Google Scholar]
- 93. Chen J, Altman GH, Karageorgiou V, et al. Human bone marrow stromal cell and ligament fibroblast responses on RGD‐modified silk fibers. J Biomed Mater Res A. 2003;67(2):559‐570. doi: 10.1002/jbm.a.10120 [DOI] [PubMed] [Google Scholar]
- 94. Kardestuncer T, McCarthy MB, Karageorgiou V, Kaplan D, Gronowicz G. RGD‐tethered silk substrate stimulates the differentiation of human tendon cells. Clin Orthop Relat Res. 2006;448:234‐239. doi: 10.1097/01.blo.0000205879.50834.fe [DOI] [PubMed] [Google Scholar]
- 95. Bhattacharjee P, Naskar D, Kim H‐W, Maiti TK, Bhattacharya D, Kundu SC. Non‐mulberry silk fibroin grafted PCL nanofibrous scaffold: promising ECM for bone tissue engineering. Eur Polym J. 2015;71:490‐509. doi: 10.1016/j.eurpolymj.2015.08.025 [DOI] [Google Scholar]
- 96. Singh BN, Pramanik K. Fabrication and evaluation of non‐mulberry silk fibroin fiber reinforced chitosan based porous composite scaffold for cartilage tissue engineering. Tissue Cell. 2018;55:83‐90. doi: 10.1016/j.tice.2018.10.003 [DOI] [PubMed] [Google Scholar]
- 97. Chouhan D, Chakraborty B, Nandi SK, Mandal BB. Role of non‐mulberry silk fibroin in deposition and regulation of extracellular matrix towards accelerated wound healing. Acta Biomater. 2017;48:157‐174. doi: 10.1016/j.actbio.2016.10.019 [DOI] [PubMed] [Google Scholar]
- 98. Musson DS, Naot D, Chhana A, et al. In vitro evaluation of a novel non‐mulberry silk scaffold for use in tendon regeneration. Tissue Eng Part A. 2015;21(9–10):1539‐1551. doi: 10.1089/ten.TEA.2014.0128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Hazra S, Nandi S, Naskar D, et al. Non‐mulberry silk fibroin biomaterial for corneal regeneration. Sci Rep. 2016;6:21840. doi: 10.1038/srep21840 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Wang J, Yin Z, Xue X, Kundu SC, Mo X, Lu S. Natural non‐mulberry silk nanoparticles for potential‐controlled drug release. Int J Mol Sci. 2016;17(12):2012. doi: 10.3390/ijms17122012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Bissoyi A, Kumar Singh A, Kumar Pattanayak S, et al. Understanding the molecular mechanism of improved proliferation and osteogenic potential of human mesenchymal stem cells grown on a polyelectrolyte complex derived from non‐mulberry silk fibroin and chitosan. Biomed Mater. 2017;13(1):015011. doi: 10.1088/1748-605X/aa890c [DOI] [PubMed] [Google Scholar]
- 102. Talukdar S, Kundu SC. A non‐mulberry silk fibroin protein based 3D in vitro tumor model for evaluation of anticancer drug activity. Adv Funct Mater. 2012;22(22):4778‐4788. doi: 10.1002/adfm.201200375 [DOI] [Google Scholar]
- 103. Humenik M, Smith AM, Scheibel T. Recombinant spider silks—biopolymers with potential for future applications. Polymers. 2011;3(1):640‐661. doi: 10.3390/polym3010640 [DOI] [Google Scholar]
- 104. Salehi S, Koeck K, Scheibel T. Spider silk for tissue engineering applications. Molecules. 2020;25(3):737. doi: 10.3390/molecules25030737 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Muller F, Zainuddin S, Scheibel T. Roll‐to‐roll production of spider silk nanofiber nonwoven meshes using centrifugal electrospinning for filtration applications. Molecules. 2020;25(23):5540. doi: 10.3390/molecules25235540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Borkner CB, Wohlrab S, Moller E, Lang G, Scheibel T. Surface modification of polymeric biomaterials using recombinant spider silk proteins. ACS Biomater Sci Eng. 2017;3(5):767‐775. doi: 10.1021/acsbiomaterials.6b00306 [DOI] [PubMed] [Google Scholar]
- 107. Gellynck K, Verdonk PC, Van Nimmen E, et al. Silkworm and spider silk scaffolds for chondrocyte support. J Mater Sci Mater Med. 2008;19(11):3399‐3409. doi: 10.1007/s10856-008-3474-6 [DOI] [PubMed] [Google Scholar]
- 108. Withanage S, Savin A, Nikolaeva V, et al. Native spider silk‐based antimicrobial hydrogels for biomedical applications. Polymers (Basel). 2021;13(11):1796. doi: 10.3390/polym13111796 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. DeSimone E, Schacht K, Pellert A, Scheibel T. Recombinant spider silk‐based bioinks. Biofabrication. 2017;9(4):044104. doi: 10.1088/1758-5090/aa90db [DOI] [PubMed] [Google Scholar]
- 110. Schacht K, Jungst T, Schweinlin M, Ewald A, Groll J, Scheibel T. Biofabrication of cell‐loaded 3D spider silk constructs. Angew Chem Int Ed Engl. 2015;54(9):2816‐2820. doi: 10.1002/anie.201409846 [DOI] [PubMed] [Google Scholar]
- 111. Rameau A, Hong RS, Djalilian H, et al. New medical device and therapeutic approvals in otolaryngology: state of the art review of 2019. OTO Open. 2020;4(2):2473974X20932506. doi: 10.1177/2473974X20932506 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Motta A, Migliaresi C, Lloyd AW, Denyer SP, Santin M. Serum protein absorption on silk fibroin fibers and films: surface opsonization and binding strength. J Bioactive Compat Polym. 2002;17(1):23‐35. doi: 10.1177/0883911502017001195 [DOI] [Google Scholar]
- 113. Motta A, Maniglio D, Migliaresi C, et al. Silk fibroin processing and thrombogenic responses. J Biomater Sci Polym Ed. 2009;20(13):1875‐1897. doi: 10.1163/156856208X399936 [DOI] [PubMed] [Google Scholar]
- 114. Guo X, Lin N, Lu S, Zhang F, Zuo B. Preparation and biocompatibility characterization of silk fibroin 3D scaffolds. ACS Appl Bio Mater. 2021;4(2):1369‐1380. doi: 10.1021/acsabm.0c01239 [DOI] [PubMed] [Google Scholar]
- 115. Zhang YQ, Zhou WL, Shen WD, et al. Synthesis, characterization and immunogenicity of silk fibroin‐L‐asparaginase bioconjugates. J Biotechnol. 2005;120(3):315‐326. doi: 10.1016/j.jbiotec.2005.06.027 [DOI] [PubMed] [Google Scholar]
- 116. Cao Y, Wang B. Biodegradation of silk biomaterials. Int J Mol Sci. 2009;10(4):1514‐1524. doi: 10.3390/ijms10041514 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Zhao Y, Zhu ZS, Guan J, Wu SJ. Processing, mechanical properties and bio‐applications of silk fibroin‐based high‐strength hydrogels. Acta Biomater. 2021;125:57‐71. doi: 10.1016/j.actbio.2021.02.018 [DOI] [PubMed] [Google Scholar]
- 118. Johari N, Moroni L, Samadikuchaksaraei A. Tuning the conformation and mechanical properties of silk fibroin hydrogels. Eur Polym J. 2020;134:109842. doi: 10.1016/j.eurpolymj.2020.109842 [DOI] [Google Scholar]
- 119. DeBari MK, King CI 3rd, Altgold TA, Abbott RD. Silk fibroin as a green material. ACS Biomater Sci Eng. 2021;7(8):3530‐3544. doi: 10.1021/acsbiomaterials.1c00493 [DOI] [PubMed] [Google Scholar]
- 120. Jiang T, Zhou P. Environment‐Induced Silk Fibroin Conformation Based on the Magnetic Resonance Spectroscopy. IntechOpen; 2011. [Google Scholar]
- 121. Han H, Ning H, Liu S, et al. Silk biomaterials with vascularization capacity. Adv Funct Mater. 2016;26(3):421‐436. doi: 10.1002/adfm.201504160 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Brown J, Lu CL, Coburn J, Kaplan DL. Impact of silk biomaterial structure on proteolysis. Acta Biomater. 2015;11:212‐221. doi: 10.1016/j.actbio.2014.09.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. Guo C, Li C, Kaplan DL. Enzymatic degradation of Bombyx mori silk materials: a review. Biomacromolecules. 2020;21(5):1678‐1686. doi: 10.1021/acs.biomac.0c00090 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Hu Y, Zhang Q, You R, Wang L, Li M. The relationship between secondary structure and biodegradation behavior of silk fibroin scaffolds. Adv Mater Sci Eng. 2012;2012:185905. doi: 10.1155/2012/185905 [DOI] [Google Scholar]
- 125. Abbott RD, Kimmerling EP, Cairns DM, Kaplan DL. Silk as a biomaterial to support long‐term three‐dimensional tissue cultures. ACS Appl Mater Interfaces. 2016;8(34):21861‐21868. doi: 10.1021/acsami.5b12114 [DOI] [PubMed] [Google Scholar]
- 126. Cebe P, Partlow BP, Kaplan DL, Wurm A, Zhuravlev E, Schick C. Silk I and silk II studied by fast scanning calorimetry. Acta Biomater. 2017;55:323‐332. doi: 10.1016/j.actbio.2017.04.001 [DOI] [PubMed] [Google Scholar]
- 127. Zhao M, Qi Z, Tao X, Newkirk C, Hu X, Lu S. Chemical, thermal, time, and enzymatic stability of silk materials with silk I structure. Int J Mol Sci. 2021;22(8):4136. doi: 10.3390/ijms22084136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Puerta M, Peresin MS, Restrepo‐Osorio A. Effects of chemical post‐treatments on structural and physicochemical properties of silk fibroin films obtained from silk fibrous waste. Front Bioeng Biotechnol. 2020;8:523949. doi: 10.3389/fbioe.2020.523949 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129. Rnjak‐Kovacina J, Tang F, Whitelock JM, Lord MS. Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications. Colloids Surf B Biointerfaces. 2016;148:130‐138. doi: 10.1016/j.colsurfb.2016.08.039 [DOI] [PubMed] [Google Scholar]
- 130. Zheng H, Zuo B. Functional silk fibroin hydrogels: preparation, properties and applications. J Mater Chem B. 2021;9(5):1238‐1258. doi: 10.1039/d0tb02099k [DOI] [PubMed] [Google Scholar]
- 131. Singh YP, Bhardwaj N, Mandal BB. Potential of agarose/silk fibroin blended hydrogel for in vitro cartilage tissue engineering. ACS Appl Mater Interfaces. 2016;8(33):21236‐21249. doi: 10.1021/acsami.6b08285 [DOI] [PubMed] [Google Scholar]
- 132. Yu LM, Liu T, Ma YL, Zhang F, Huang YC, Fan ZH. Fabrication of silk‐hyaluronan composite as a potential scaffold for tissue repair. Front Bioeng Biotechnol. 2020;8:578988. doi: 10.3389/fbioe.2020.578988 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133. Maniglio D, Bonani W, Migliaresi C, Motta A. Silk fibroin porous scaffolds by N2O foaming. J Biomater Sci Polym Ed. 2018;29(5):491‐506. doi: 10.1080/09205063.2018.1423811 [DOI] [PubMed] [Google Scholar]
- 134. Ferreira BMP, Andersson N, Atterling E, Engqvist J, Hall S, Dicko C. 3D structure and mechanics of silk sponge scaffolds is governed by larger pore sizes. Original research. Front Mater. 2020;7:211. [Google Scholar]
- 135. Hardy JG, Geissler SA, Aguilar D Jr, et al. Instructive conductive 3D silk foam‐based bone tissue scaffolds enable electrical stimulation of stem cells for enhanced osteogenic differentiation. Macromol Biosci. 2015;15(11):1490‐1496. doi: 10.1002/mabi.201500171 [DOI] [PubMed] [Google Scholar]
- 136. Wang Q, Han G, Yan S, Zhang Q. 3D printing of silk fibroin for biomedical applications. Materials (Basel). 2019;12(3):504. doi: 10.3390/ma12030504 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Mwangi TK, Bowles RD, Tainter DM, Bell RD, Kaplan DL, Setton LA. Synthesis and characterization of silk fibroin microparticles for intra‐articular drug delivery. Int J Pharm. 2015;485(1–2):7‐14. doi: 10.1016/j.ijpharm.2015.02.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138. Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials. 2004;25(7–8):1289‐1297. doi: 10.1016/j.biomaterials.2003.08.045 [DOI] [PubMed] [Google Scholar]
- 139. Agostinacchio F, Maniglio D, Callone E, Migliaresi C, Dire S, Motta A. A novel and selective silk fibroin fragmentation method. Soft Matter. 2021;17(28):6863‐6872. doi: 10.1039/d1sm00566a [DOI] [PubMed] [Google Scholar]
- 140. Floren M, Migliaresi C, Motta A. Processing techniques and applications of silk hydrogels in bioengineering. J Funct Biomater. 2016;7(3):26. doi: 10.3390/jfb7030026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141. Su D, Yao M, Liu J, Zhong Y, Chen X, Shao Z. Enhancing mechanical properties of silk fibroin hydrogel through restricting the growth of beta‐sheet domains. ACS Appl Mater Interfaces. 2017;9(20):17489‐17498. doi: 10.1021/acsami.7b04623 [DOI] [PubMed] [Google Scholar]
- 142. Yucel T, Cebe P, Kaplan DL. Vortex‐induced injectable silk fibroin hydrogels. Biophys J. 2009;97(7):2044‐2050. doi: 10.1016/j.bpj.2009.07.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143. Wang L, Song D, Zhang X, et al. Silk‐graphene hybrid hydrogels with multiple cues to induce nerve cell behavior. ACS Biomater Sci Eng. 2019;5(2):613‐622. doi: 10.1021/acsbiomaterials.8b01481 [DOI] [PubMed] [Google Scholar]
- 144. Hu X, Lu Q, Sun L, et al. Biomaterials from ultrasonication‐induced silk fibroin‐hyaluronic acid hydrogels. Biomacromolecules. 2010;11(11):3178‐3188. doi: 10.1021/bm1010504 [DOI] [PubMed] [Google Scholar]
- 145. Kim UJ, Park J, Li C, Jin HJ, Valluzzi R, Kaplan DL. Structure and properties of silk hydrogels. Biomacromolecules. 2004;5(3):786‐792. doi: 10.1021/bm0345460 [DOI] [PubMed] [Google Scholar]
- 146. Nagarkar S, Patil A, Lele A, Bhat S, Bellare J, Mashelkar RA. Some mechanistic insights into the gelation of regenerated silk fibroin sol. Ind Eng Chem Res. 2009;48(17):8014‐8023. doi: 10.1021/ie801723f [DOI] [Google Scholar]
- 147. Yao D, Dong S, Lu Q, et al. Salt‐leached silk scaffolds with tunable mechanical properties. Biomacromolecules. 2012;13(11):3723‐3729. doi: 10.1021/bm301197h [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148. Rnjak‐Kovacina J, Wray LS, Burke KA, et al. Lyophilized silk sponges: a versatile biomaterial platform for soft tissue engineering. ACS Biomater Sci Eng. 2015;1(4):260‐270. doi: 10.1021/ab500149p [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149. Cengiz IF, Maia FR, da Silva MA, et al. Entrapped in cage (EiC) scaffolds of 3D‐printed polycaprolactone and porous silk fibroin for meniscus tissue engineering. Biofabrication. 2020;12(2):025028. doi: 10.1088/1758-5090/ab779f [DOI] [PubMed] [Google Scholar]
- 150. Cai J, Zhang L, Chen J, Chen S. Silk fibroin coating through EDC/NHS crosslink is an effective method to promote graft remodeling of a polyethylene terephthalate artificial ligament. J Biomater Appl. 2019;33(10):1407‐1414. doi: 10.1177/0885328219836625 [DOI] [PubMed] [Google Scholar]
- 151. Santi S, Mancini I, Dire S, et al. A bio‐inspired multifunctionalized silk fibroin. ACS Biomater Sci Eng. 2021;7(2):507‐516. doi: 10.1021/acsbiomaterials.0c01567 [DOI] [PubMed] [Google Scholar]
- 152. Murphy AR, St John P, Kaplan DL. Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation. Biomaterials. 2008;29(19):2829‐2838. doi: 10.1016/j.biomaterials.2008.03.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153. Acharya C, Hinz B, Kundu SC. The effect of lactose‐conjugated silk biomaterials on the development of fibrogenic fibroblasts. Biomaterials. 2008;29(35):4665‐4675. doi: 10.1016/j.biomaterials.2008.08.033 [DOI] [PubMed] [Google Scholar]
- 154. Galeotti F, Andicsová A, Bertini F, Botta C. A versatile click‐grafting approach to surface modification of silk fibroin films. J Mater Sci. 2013;48:7004‐7010. doi: 10.1007/s10853-013-7509-0 [DOI] [Google Scholar]
- 155. Gotoh Y, Tsukada M, Aiba S, Minoura N. Chemical modification of silk fibroin with N‐acetyl‐chito‐oligosaccharides. Int J Biol Macromol. 1996;18(1–2):19‐26. doi: 10.1016/0141-8130(95)01039-4 [DOI] [PubMed] [Google Scholar]
- 156. McGill M, Grant JM, Kaplan DL. Enzyme‐mediated conjugation of peptides to silk fibroin for facile hydrogel functionalization. Ann Biomed Eng. 2020;48(7):1905‐1915. doi: 10.1007/s10439-020-02503-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157. Sofia S, McCarthy MB, Gronowicz G, Kaplan DL. Functionalized silk‐based biomaterials for bone formation. J Biomed Mater Res. 2001;54(1):139‐148. doi: [DOI] [PubMed] [Google Scholar]
- 158. Saleem M, Rasheed S, Yougen C. Silk fibroin/hydroxyapatite scaffold: a highly compatible material for bone regeneration. Sci Technol Adv Mater. 2020;21(1):242‐266. doi: 10.1080/14686996.2020.1748520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159. Kim DK, Kim JI, Hwang TI, Sim BR, Khang G. Bioengineered osteoinductive Broussonetia kazinoki/silk fibroin composite scaffolds for bone tissue regeneration. ACS Appl Mater Interfaces. 2017;9(2):1384‐1394. doi: 10.1021/acsami.6b14351 [DOI] [PubMed] [Google Scholar]
- 160. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL. Electrospun silk‐BMP‐2 scaffolds for bone tissue engineering. Biomaterials. 2006;27(16):3115‐3124. doi: 10.1016/j.biomaterials.2006.01.022 [DOI] [PubMed] [Google Scholar]
- 161. Zhang Y, Wu C, Luo T, Li S, Cheng X, Miron RJ. Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone. 2012;51(4):704‐713. doi: 10.1016/j.bone.2012.06.029 [DOI] [PubMed] [Google Scholar]
- 162. Wang Q, Zhang Y, Li B, Chen L. Controlled dual delivery of low doses of BMP‐2 and VEGF in a silk fibroin‐nanohydroxyapatite scaffold for vascularized bone regeneration. J Mater Chem B. 2017;5(33):6963‐6972. doi: 10.1039/c7tb00949f [DOI] [PubMed] [Google Scholar]
- 163. Ode Boni BO, Bakadia BM, Osi AR, et al. Immune response to silk Sericin‐fibroin composites: potential immunogenic elements and alternatives for immunomodulation. Macromol Biosci. 2022;22(1):e2100292. doi: 10.1002/mabi.202100292 [DOI] [PubMed] [Google Scholar]
- 164. Fan J‐B, Wu L‐P, Chen L‐S, Mao X‐Y, Ren F‐Z. Antioxidant activities of silk sericin from silkworm Bombyx mori . J Food Biochem. 2009;33(1):74‐88. doi: 10.1111/j.1745-4514.2008.00204.x [DOI] [Google Scholar]
- 165. Padamwar MN, Pawar AP, Daithankar AV, Mahadik KR. Silk sericin as a moisturizer: an in vivo study. J Cosmet Dermatol. 2005;4(4):250‐257. doi: 10.1111/j.1473-2165.2005.00200.x [DOI] [PubMed] [Google Scholar]
- 166. Kumar JP, Alam S, Jain AK, Ansari KM, Mandal BB. Protective activity of silk Sericin against UV radiation‐induced skin damage by downregulating oxidative stress. ACS Appl Bio Mater. 2018;1(6):2120‐2132. doi: 10.1021/acsabm.8b00558 [DOI] [PubMed] [Google Scholar]
- 167. Arango MC, Montoya Y, Peresin MS, Bustamante J, Álvarez‐López C. Silk sericin as a biomaterial for tissue engineering: a review. Int J Polym Mater Polym Biomater. 2021;70(16):1115‐1129. doi: 10.1080/00914037.2020.1785454 [DOI] [Google Scholar]
- 168. Baptista‐Silva S, Borges S, Costa‐Pinto AR, et al. In situ forming silk Sericin‐based hydrogel: a novel wound healing biomaterial. ACS Biomater Sci Eng. 2021;7(4):1573‐1586. doi: 10.1021/acsbiomaterials.0c01745 [DOI] [PubMed] [Google Scholar]
- 169. Arango MC, Álvarez‐López C. Effect of freezing temperature on the properties of lyophilized silk sericin scaffold. Mater Res Express. 2019;6(9):095414. doi: 10.1088/2053-1591/ab3594 [DOI] [Google Scholar]
- 170. Yun H, Kim MK, Kwak HW, Lee JY, Kim MH, Lee KH. The role of glycerol and water in flexible silk sericin film. Int J Biol Macromol. 2016;82:945‐951. doi: 10.1016/j.ijbiomac.2015.11.016 [DOI] [PubMed] [Google Scholar]
- 171. Chen CS, Zeng F, Xiao X, et al. Three‐dimensionally printed silk‐Sericin‐based hydrogel scaffold: a promising visualized dressing material for real‐time monitoring of wounds. ACS Appl Mater Interfaces. 2018;10(40):33879‐33890. doi: 10.1021/acsami.8b10072 [DOI] [PubMed] [Google Scholar]
- 172. Aramwit P, Kanokpanont S, De‐Eknamkul W, Kamei K, Srichana T. The effect of sericin with variable amino‐acid content from different silk strains on the production of collagen and nitric oxide. J Biomater Sci Polym Ed. 2009;20(9):1295‐1306. doi: 10.1163/156856209X453006 [DOI] [PubMed] [Google Scholar]
- 173. Nayak S, Dey S, Kundu SC. Skin equivalent tissue‐engineered construct: co‐cultured fibroblasts/ keratinocytes on 3D matrices of sericin hope cocoons. PLoS One. 2013;8(9):e74779. doi: 10.1371/journal.pone.0074779 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174. Lamboni L, Gauthier M, Yang G, Wang Q. Silk sericin: a versatile material for tissue engineering and drug delivery. Biotechnol Adv. 2015;33(8):1855‐1867. doi: 10.1016/j.biotechadv.2015.10.014 [DOI] [PubMed] [Google Scholar]
- 175. Nayak S, Dey T, Naskar D, Kundu SC. The promotion of osseointegration of titanium surfaces by coating with silk protein sericin. Biomaterials. 2013;34(12):2855‐2864. doi: 10.1016/j.biomaterials.2013.01.019 [DOI] [PubMed] [Google Scholar]
- 176. Kumar JP, Bhardwaj N, Mandal BB. Cross‐linked silk sericin–gelatin 2D and 3D matrices for prospective tissue engineering applications. RSC Adv. 2016;6(107):105125‐105136. doi: 10.1039/C6RA18654H [DOI] [Google Scholar]
- 177. He M, Hu H, Wang P, et al. Preparation of a bio‐composite of sericin‐g‐PMMA via HRP‐mediated graft copolymerization. Int J Biol Macromol. 2018;117:323‐330. doi: 10.1016/j.ijbiomac.2018.05.190 [DOI] [PubMed] [Google Scholar]
- 178. Hang Y, Zhang Y, Jin Y, Shao H, Hu X. Preparation and characterization of electrospun silk fibroin/sericin blend fibers. J Mater Res. 2011;26(23):2931‐2937. doi: 10.1557/jmr.2011.356 [DOI] [Google Scholar]
- 179. Timin AS, Muslimov AR, Zyuzin MV, et al. Multifunctional scaffolds with improved antimicrobial properties and osteogenicity based on piezoelectric electrospun fibers decorated with bioactive composite microcapsules. ACS Appl Mater Interfaces. 2018;10(41):34849‐34868. doi: 10.1021/acsami.8b09810 [DOI] [PubMed] [Google Scholar]
- 180. Bhattacharjee P, Naskar D, Maiti TK, Bhattacharya D, Kundu SC. Investigating the potential of combined growth factors delivery, from non‐mulberry silk fibroin grafted poly(ɛ‐caprolactone)/hydroxyapatite nanofibrous scaffold, in bone tissue engineering. Appl Mater Today. 2016;5:52‐67. doi: 10.1016/j.apmt.2016.09.007 [DOI] [Google Scholar]
- 181. Naskar D, Ghosh AK, Mandal M, Das P, Nandi SK, Kundu SC. Dual growth factor loaded nonmulberry silk fibroin/carbon nanofiber composite 3D scaffolds for in vitro and in vivo bone regeneration. Biomaterials. 2017;136:67‐85. doi: 10.1016/j.biomaterials.2017.05.014 [DOI] [PubMed] [Google Scholar]
- 182. Wang X, Wenk E, Zhang X, Meinel L, Vunjak‐Novakovic G, Kaplan DL. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release. 2009;134(2):81‐90. doi: 10.1016/j.jconrel.2008.10.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183. Kharaghani D, Kurniwan EB, Khan MQ, Yoshiko Y. MiRNA‐nanofiber, the next generation of bioactive scaffolds for bone regeneration: a review. Micromachines (Basel). 2021;12(12):1472. doi: 10.3390/mi12121472 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184. James EN, Van Doren E, Li C, Kaplan DL. Silk biomaterials‐mediated miRNA functionalized orthopedic devices. Tissue Eng Part A. 2019;25(1–2):12‐23. doi: 10.1089/ten.TEA.2017.0455 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185. Li J, Wu S, Kim E, et al. Electrobiofabrication: electrically based fabrication with biologically derived materials. Biofabrication. 2019;11(3):032002. doi: 10.1088/1758-5090/ab06ea [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186. Toprakcioglu Z, Levin A, Knowles TPJ. Hierarchical biomolecular emulsions using 3‐D microfluidics with uniform surface chemistry. Biomacromolecules. 2017;18(11):3642‐3651. doi: 10.1021/acs.biomac.7b01159 [DOI] [PubMed] [Google Scholar]
- 187. Konwarh R, Gupta P, Mandal BB. Silk‐microfluidics for advanced biotechnological applications: a progressive review. Biotechnol Adv. 2016;34(5):845‐858. doi: 10.1016/j.biotechadv.2016.05.001 [DOI] [PubMed] [Google Scholar]
- 188. Cheng J, Park D, Jun Y, Lee J, Hyun J, Lee SH. Biomimetic spinning of silk fibers and in situ cell encapsulation. Lab Chip. 2016;16(14):2654‐2661. doi: 10.1039/c6lc00488a [DOI] [PubMed] [Google Scholar]
- 189. Jeon HY, Jung SH, Jung YM, Kim YM, Ghandehari H, Ha KS. Array‐based high‐throughput analysis of silk‐elastinlike protein polymer degradation and C‐peptide release by proteases. Anal Chem. 2016;88(10):5398‐5405. doi: 10.1021/acs.analchem.6b00739 [DOI] [PubMed] [Google Scholar]
- 190. Peng Q, Zhang Y, Lu L, et al. Recombinant spider silk from aqueous solutions via a bio‐inspired microfluidic chip. Sci Rep. 2016;6:36473. doi: 10.1038/srep36473 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191. Choudhary T, Rajamanickam GP, Dendukuri D. Woven electrochemical fabric‐based test sensors (WEFTS): a new class of multiplexed electrochemical sensors. Lab Chip. 2015;15(9):2064‐2072. doi: 10.1039/c5lc00041f [DOI] [PubMed] [Google Scholar]
- 192. Brody H. Biomaterials. Nature. 2015;519(7544):S1. doi: 10.1038/519S1a [DOI] [PubMed] [Google Scholar]
- 193. Bhandari P, Narahari T, Dendukuri D. ‘Fab‐chips’: a versatile, fabric‐based platform for low‐cost, rapid and multiplexed diagnostics. Lab Chip. 2011;11(15):2493‐2499. doi: 10.1039/c1lc20373h [DOI] [PubMed] [Google Scholar]
- 194. Domachuk P, Tsioris K, Omenetto FG, Kaplan DL. Bio‐microfluidics: biomaterials and biomimetic designs. Adv Mater. 2010;22(2):249‐260. doi: 10.1002/adma.200900821 [DOI] [PubMed] [Google Scholar]
- 195. Zhu J, Marchant RE. Design properties of hydrogel tissue‐engineering scaffolds. Expert Rev Med Devices. 2011;8(5):607‐626. doi: 10.1586/erd.11.27 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196. Bhunia BK, Mandal BB. Exploring gelation and physicochemical behavior of in situ bioresponsive silk hydrogels for disc degeneration therapy. ACS Biomater Sci Eng. 2019;5(2):870‐886. doi: 10.1021/acsbiomaterials.8b01099 [DOI] [PubMed] [Google Scholar]
- 197. Cassidy JJ, Hiltner A, Baer E. Hierarchical structure of the intervertebral disc. Connect Tissue Res. 1989;23(1):75‐88. doi: 10.3109/03008208909103905 [DOI] [PubMed] [Google Scholar]
- 198. Park SH, Cho H, Gil ES, Mandal BB, Min BH, Kaplan DL. Silk‐fibrin/hyaluronic acid composite gels for nucleus pulposus tissue regeneration. Tissue Eng Part A. 2011;17(23–24):2999‐3009. doi: 10.1089/ten.TEA.2010.0747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199. Chung TW, Chen WP, Tai PW, Lo HY, Wu TY. Roles of silk fibroin on characteristics of hyaluronic acid/silk fibroin hydrogels for tissue engineering of nucleus pulposus. Materials (Basel). 2020;13(12):2750. doi: 10.3390/ma13122750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200. Hu J, Chen B, Guo F, et al. Injectable silk fibroin/polyurethane composite hydrogel for nucleus pulposus replacement. J Mater Sci Mater Med. 2012;23(3):711‐722. doi: 10.1007/s10856-011-4533-y [DOI] [PubMed] [Google Scholar]
- 201. Hu J, Lu Y, Cai L, et al. Functional compressive mechanics and tissue biocompatibility of an injectable SF/PU hydrogel for nucleus pulposus replacement. Sci Rep. 2017;7(1):2347. doi: 10.1038/s41598-017-02497-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202. Murab S, Samal J, Shrivastava A, Ray AR, Pandit A, Ghosh S. Glucosamine loaded injectable silk‐in‐silk integrated system modulate mechanical properties in bovine ex‐vivo degenerated intervertebral disc model. Biomaterials. 2015;55:64‐83. doi: 10.1016/j.biomaterials.2015.03.032 [DOI] [PubMed] [Google Scholar]
- 203. Lau KS, Partridge EA, Grigorian A, et al. Complex N‐glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 2007;129(1):123‐134. doi: 10.1016/j.cell.2007.01.049 [DOI] [PubMed] [Google Scholar]
- 204. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci. 2000;113(Pt 2):193‐205. [DOI] [PubMed] [Google Scholar]
- 205. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24(24):4337‐4351. doi: 10.1016/s0142-9612(03)00340-5 [DOI] [PubMed] [Google Scholar]
- 206. Zeng C, Yang Q, Zhu M, et al. Silk fibroin porous scaffolds for nucleus pulposus tissue engineering. Mater Sci Eng C Mater Biol Appl. 2014;37:232‐240. doi: 10.1016/j.msec.2014.01.012 [DOI] [PubMed] [Google Scholar]
- 207. Park SH, Gil ES, Mandal BB, et al. Annulus fibrosus tissue engineering using lamellar silk scaffolds. J Tissue Eng Regen Med. 2012;6(Suppl 3):s24‐s33. doi: 10.1002/term.541 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 208. Park SH, Gil ES, Cho H, et al. Intervertebral disk tissue engineering using biphasic silk composite scaffolds. Tissue Eng Part A. 2012;18(5–6):447‐458. doi: 10.1089/ten.TEA.2011.0195 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209. See EY, Toh SL, Goh JC. Simulated intervertebral disc‐like assembly using bone marrow‐derived mesenchymal stem cell sheets and silk scaffolds for annulus fibrosus regeneration. J Tissue Eng Regen Med. 2012;6(7):528‐535. doi: 10.1002/term.457 [DOI] [PubMed] [Google Scholar]
- 210. See EY, Toh SL, Goh JC. Effects of radial compression on a novel simulated intervertebral disc‐like assembly using bone marrow‐derived mesenchymal stem cell cell‐sheets for annulus fibrosus regeneration. Spine (Phila Pa 1976). 2011;36(21):1744‐1751. doi: 10.1097/brs.0b013e31821986b3 [DOI] [PubMed] [Google Scholar]
- 211. Bhunia BK, Kaplan DL, Mandal BB. Silk‐based multilayered angle‐ply annulus fibrosus construct to recapitulate form and function of the intervertebral disc. Proc Natl Acad Sci U S A. 2018;115(3):477‐482. doi: 10.1073/pnas.1715912115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 212. Zhang T, Du L, Zhao J, et al. Biomimetic angle‐ply multi‐lamellar scaffold for annulus fibrosus tissue engineering. J Mater Sci Mater Med. 2020;31(8):67. doi: 10.1007/s10856-020-06404-7 [DOI] [PubMed] [Google Scholar]
- 213. Saric M, Scheibel T. Engineering of silk proteins for materials applications. Curr Opin Biotechnol. 2019;60:213‐220. doi: 10.1016/j.copbio.2019.05.005 [DOI] [PubMed] [Google Scholar]
- 214. Chang G, Kim HJ, Kaplan D, Vunjak‐Novakovic G, Kandel RA. Porous silk scaffolds can be used for tissue engineering annulus fibrosus. Eur Spine J. 2007;16(11):1848‐1857. doi: 10.1007/s00586-007-0364-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 215. Frauchiger DA, Heeb SR, May RD, Woltje M, Benneker LM, Gantenbein B. Differentiation of MSC and annulus fibrosus cells on genetically engineered silk fleece‐membrane‐composites enriched for GDF‐6 or TGF‐beta3. J Orthop Res. 2018;36(5):1324‐1333. doi: 10.1002/jor.23778 [DOI] [PubMed] [Google Scholar]
- 216. Bhattacharjee M, Miot S, Gorecka A, et al. Oriented lamellar silk fibrous scaffolds to drive cartilage matrix orientation: towards annulus fibrosus tissue engineering. Acta Biomater. 2012;8(9):3313‐3325. doi: 10.1016/j.actbio.2012.05.023 [DOI] [PubMed] [Google Scholar]
- 217. Bhattacharjee M, Chawla S, Chameettachal S, Murab S, Bhavesh NS, Ghosh S. Role of chondroitin sulphate tethered silk scaffold in cartilaginous disc tissue regeneration. Biomed Mater. 2016;11(2):025014. doi: 10.1088/1748-6041/11/2/025014 [DOI] [PubMed] [Google Scholar]
- 218. Bhattacharjee M, Chameettachal S, Pahwa S, Ray AR, Ghosh S. Strategies for replicating anatomical cartilaginous tissue gradient in engineered intervertebral disc. ACS Appl Mater Interfaces. 2014;6(1):183‐193. doi: 10.1021/am403835t [DOI] [PubMed] [Google Scholar]
- 219. Varghese S, Hwang NS, Canver AC, Theprungsirikul P, Lin DW, Elisseeff J. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol. 2008;27(1):12‐21. doi: 10.1016/j.matbio.2007.07.002 [DOI] [PubMed] [Google Scholar]
- 220. Chou AI, Bansal A, Miller GJ, Nicoll SB. The effect of serial monolayer passaging on the collagen expression profile of outer and inner anulus fibrosus cells. Spine (Phila Pa 1976). 2006;31(17):1875‐1881. doi: 10.1097/01.brs.0000229222.98051.9a [DOI] [PubMed] [Google Scholar]
- 221. Costa JB, Silva‐Correia J, Ribeiro VP, da Silva MA, Oliveira JM, Reis RL. Engineering patient‐specific bioprinted constructs for treatment of degenerated intervertebral disc. Mater Today Commun. 2019;19:506‐512. doi: 10.1016/j.mtcomm.2018.01.011 [DOI] [Google Scholar]
- 222. Frauchiger DA, May RD, Bakirci E, et al. Genipin‐enhanced fibrin hydrogel and novel silk for intervertebral disc repair in a loaded bovine organ culture model. J Funct Biomater. 2018;9(3):40. doi: 10.3390/jfb9030040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 223. Rajkhowa R, Gupta VB, Kothari VK. Tensile stress–strain and recovery behavior of Indian silk fibers and their structural dependence. J Appl Polym Sci. 2000;77(11):2418‐2429. doi: [DOI] [Google Scholar]
- 224. Dash R, Ghosh SK, Kaplan DL, Kundu SC. Purification and biochemical characterization of a 70 kDa sericin from tropical tasar silkworm, Antheraea mylitta . Comp Biochem Physiol B Biochem Mol Biol. 2007;147(1):129‐134. doi: 10.1016/j.cbpb.2007.01.009 [DOI] [PubMed] [Google Scholar]
- 225. Ahmad R, Kamra A, Hasnain SE. Fibroin silk proteins from the nonmulberry silkworm Philosamia ricini are biochemically and immunochemically distinct from those of the mulberry silkworm Bombyx mori . DNA Cell Biol. 2004;23(3):149‐154. doi: 10.1089/104454904322964742 [DOI] [PubMed] [Google Scholar]
- 226. Kasoju N, Bhonde RR, Bora U. Preparation and characterization of Antheraea assama silk fibroin based novel non‐woven scaffold for tissue engineering applications. J Tissue Eng Regen Med. 2009;3(7):539‐552. doi: 10.1002/term.196 [DOI] [PubMed] [Google Scholar]
- 227. Andiappan M, Kumari T, Sundaramoorthy S, Meiyazhagan G, Manoharan P, Venkataraman G. Comparison of eri and tasar silk fibroin scaffolds for biomedical applications. Prog Biomater. 2016;5:81‐91. doi: 10.1007/s40204-016-0047-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 228. Yazawa K, Tatebayashi Y, Kajiura Z. Eri silkworm spins mechanically robust silk fibers regardless of reeling speed. J Exp Biol. 2022;225(3):jeb243458. doi: 10.1242/jeb.243458 [DOI] [PubMed] [Google Scholar]
- 229. Janzen DH. Two Ways to Be a Tropical Big Moth: Santa Rosa Saturniids and Sphingids. Department of Biology, University of Pennsylvania; 1984. [Google Scholar]
- 230. Sonwalker TN. Handbook of Silk Technology. New Age International Publisher; 1991. [Google Scholar]
- 231. Teshome A, Raina SK, Vollrath F. Structure and properties of silk from the African wild silkmoth Gonometa postica reared indoors. J Insect Sci. 2014;14:36. doi: 10.1093/jis/14.1.36 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 232. Mhuka V, Dube S, Nindi MM. Chemical, structural and thermal properties of Gonometa postica silk fibroin, a potential biomaterial. Int J Biol Macromol. 2013;52:305‐311. doi: 10.1016/j.ijbiomac.2012.09.010 [DOI] [PubMed] [Google Scholar]
- 233. Ngoka BM, Kioko EN, Raina SK, Mueke JM, Kimbu DM. Semi‐captive rearing of the African wild silkmoth Gonometa postica (Lepidoptera: Lasiocampidae) on an indigenous and a non‐indigenous host plant in Kenya. Int J Trop Insect Sci. 2007;27(3–4):183‐190. doi: 10.1017/S1742758407883160 [DOI] [Google Scholar]
- 234. Yamada H, Kozo T. Characterization of silk proteins in the cocoon fibers of Cricula trifenestrata . Int J Wild Silkmoth Silk. 2001;6:47‐51. [Google Scholar]
- 235. Hridya H, Guha L, Mazumdar M, Sarkar BN, Vijayakumar S, Borpuzari P. Probing the potentiality of the defoliator Cricula trifenestrata Helfer silk: a revisit. Bull Natl Res Cent. 2021;45(1):215. doi: 10.1186/s42269-021-00669-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 236. Nindhia T, Knejzlik Z, Ruml T, Nindhia T. Tensile properties and biocompatibility of Indonesian wild silk Cricula trifenestrata: a preliminary study. J Med Bioeng. 2014;3:140‐143. doi: 10.12720/jomb.3.2.140-143 [DOI] [Google Scholar]
- 237. Li X, Yan S, Qu J, et al. Soft freezing‐induced self‐assembly of silk fibroin for tunable gelation. Int J Biol Macromol. 2018;117:691‐695. doi: 10.1016/j.ijbiomac.2018.05.223 [DOI] [PubMed] [Google Scholar]
- 238. Kadakia PU, Jain E, Hixon KR, Eberlin CT, Sell SA. Sonication induced silk fibroin cryogels for tissue engineering applications. Mater Res Express. 2016;3(5):055401. doi: 10.1088/2053-1591/3/5/055401 [DOI] [Google Scholar]
- 239. Toprakcioglu Z, Knowles TPJ. Shear‐mediated sol‐gel transition of regenerated silk allows the formation of Janus‐like microgels. Sci Rep. 2021;11(1):6673. doi: 10.1038/s41598-021-85199-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 240. Lu Q, Huang Y, Li M, et al. Silk fibroin electrogelation mechanisms. Acta Biomater. 2011;7(6):2394‐2400. doi: 10.1016/j.actbio.2011.02.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 241. Chen P, Kim HS, Park C‐Y, Kim H‐S, Chin I‐J, Jin H‐J. pH‐triggered transition of silk fibroin from spherical micelles to nanofibrils in water. Macromol Res. 2008;16(6):539‐543. doi: 10.1007/BF03218556 [DOI] [Google Scholar]
- 242. Hirlekar S, Ray D, Aswal VK, Prabhune A, Nisal A, Ravindranathan S. Silk fibroin‐sodium dodecyl sulfate gelation: molecular, structural, and rheological insights. Langmuir. 2019;35(46):14870‐14878. doi: 10.1021/acs.langmuir.9b02402 [DOI] [PubMed] [Google Scholar]
- 243. Kim SH, Yeon YK, Lee JM, et al. Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing. Nat Commun. 2018;9(1):1620. doi: 10.1038/s41467-018-03759-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 244. Bessonov IV, Rochev YA, Arkhipova AC, et al. Fabrication of hydrogel scaffolds via photocrosslinking of methacrylated silk fibroin. Biomed Mater. 2019;14(3):034102. doi: 10.1088/1748-605X/ab04e0 [DOI] [PubMed] [Google Scholar]
- 245. Piluso S, Flores Gomez D, Dokter I, et al. Rapid and cytocompatible cell‐laden silk hydrogel formation via riboflavin‐mediated crosslinking. J Mater Chem B. 2020;8(41):9566‐9575. doi: 10.1039/d0tb01731k [DOI] [PubMed] [Google Scholar]
- 246. Whittaker JL, Choudhury NR, Dutta NK, Zannettino A. Facile and rapid ruthenium mediated photo‐crosslinking of Bombyx mori silk fibroin. J Mater Chem B. 2014;2(37):6259‐6270. doi: 10.1039/c4tb00698d [DOI] [PubMed] [Google Scholar]
- 247. Kim MH, Kim BS, Lee J, Cho D, Kwon OH, Park WH. Silk fibroin/hydroxyapatite composite hydrogel induced by gamma‐ray irradiation for bone tissue engineering. Biomater Res. 2017;21:12. doi: 10.1186/s40824-017-0098-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 248. Neo PY, Shi P, Goh JC, Toh SL. Characterization and mechanical performance study of silk/PVA cryogels: towards nucleus pulposus tissue engineering. Biomed Mater. 2014;9(6):065002. doi: 10.1088/1748-6041/9/6/065002 [DOI] [PubMed] [Google Scholar]
- 249. Ghorbani M, Ai J, Nourani MR, et al. Injectable natural polymer compound for tissue engineering of intervertebral disc: in vitro study. Mater Sci Eng C Mater Biol Appl. 2017;80:502‐508. doi: 10.1016/j.msec.2017.06.007 [DOI] [PubMed] [Google Scholar]
- 250. Hofmann S, Hilbe M, Fajardo RJ, et al. Remodeling of tissue‐engineered bone structures in vivo. Eur J Pharm Biopharm. 2013;85(1):119‐129. doi: 10.1016/j.ejpb.2013.02.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
